Andrew J. Saykin

Andrew J. Saykin's AcademicInfluence.com Rankings

Andrew J. Saykin

Psychology

#1702

World Rank

#2036

Historical Rank

Neuropsychology

#31

World Rank

#32

Historical Rank

psychology Degrees

Andrew J. Saykin

Biology

#4402

World Rank

#6568

Historical Rank

Genetics

#354

World Rank

#416

Historical Rank

Neuroscience

#463

World Rank

#482

Historical Rank

biology Degrees

Download Badge

Psychology
Biology

Why Is Andrew J. Saykin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Andrew J. Saykin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) (1656)
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease (2014) (1634)
Analysis of shared heritability in common disorders of the brain (2016) (1385)
Neuropsychological function in schizophrenia. Selective impairment in memory and learning. (1991) (1202)
Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. (1994) (1118)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
Candidate mechanisms for chemotherapy-induced cognitive changes (2007) (800)
Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection (1991) (773)
Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging : A meta-analytic study (1998) (766)
Common genetic variants influence human subcortical brain structures (2015) (731)
Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. (2002) (720)
Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) (716)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data (2014) (646)
The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception (2012) (553)
Neuropsychological Assessment of Neuropsychiatric Disorders (1988) (519)
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception (2012) (513)
Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI (2006) (510)
Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort (2009) (494)
Differential Working Memory Load Effects after Mild Traumatic Brain Injury (2001) (484)
The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans (2010) (473)
Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. (2010) (440)
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. (2010) (426)
Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans (2010) (395)
The characterisation of subjective cognitive decline (2020) (383)
Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults (2015) (381)
Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease (2009) (366)
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans (2010) (360)
The genetic architecture of the human cerebral cortex (2018) (355)
Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort (2010) (351)
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network (2016) (341)
Implementation of subjective cognitive decline criteria in research studies (2017) (333)
Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease (2013) (318)
Brain activation during working memory 1 month after mild traumatic brain injury (1999) (317)
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study (2018) (316)
The relationship of APOE genotype to neuropsychological performance in long‐term cancer survivors treated with standard dose chemotherapy (2003) (312)
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis (2012) (308)
Cognitive function in breast cancer patients prior to adjuvant treatment (2008) (306)
Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies. (2015) (296)
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome (2018) (288)
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception (2015) (287)
Temporal lobectomy for refractory epilepsy. (1996) (284)
Deep Learning in Alzheimer's Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data (2019) (281)
Metabolic network failures in Alzheimer's disease: A biochemical road map (2017) (280)
Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study (2010) (279)
Executive dysfunction following traumatic brain injury: neural substrates and treatment strategies. (2002) (277)
Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease (2011) (274)
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study (2018) (272)
Voxelwise genome-wide association study (vGWAS) (2010) (269)
Pathway analysis of genomic data: concepts, methods, and prospects for future development. (2012) (267)
Mechanisms of working memory dysfunction after mild and moderate TBI: evidence from functional MRI and neurogenetics. (2006) (264)
Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort (2010) (250)
Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. (2007) (249)
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly (2010) (248)
In-home virtual reality videogame telerehabilitation in adolescents with hemiplegic cerebral palsy. (2010) (242)
Novel genetic loci associated with hippocampal volume (2017) (238)
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative (2018) (225)
Differential Memory Test Sensitivity for Diagnosing Amnestic Mild Cognitive Impairment and Predicting Conversion to Alzheimer's Disease (2009) (220)
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans (2015) (219)
Cognitive‐behavioral management of chemotherapy‐related cognitive change (2007) (219)
Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. (2012) (218)
Regional brain function in schizophrenia. I. A positron emission tomography study. (1987) (215)
Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conference. (2015) (215)
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials (2017) (214)
Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. (2003) (211)
Development of CBT for chemotherapy‐related cognitive change: results of a waitlist control trial (2012) (210)
The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement (2017) (206)
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology (2016) (201)
Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. (2004) (200)
Four distinct trajectories of tau deposition identified in Alzheimer’s disease (2021) (200)
Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof-of-concept and roadmap for future studies (2016) (198)
Verbal fluency performance in amnestic MCI and older adults with cognitive complaints. (2008) (197)
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
Novel genetic loci underlying human intracranial volume identified through genome-wide association (2016) (192)
Subjective cognitive decline and rates of incident Alzheimer’s disease and non-Alzheimer’s disease dementia (2018) (188)
Structural and functional magnetic resonance imaging of autism spectrum disorders (2011) (188)
Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. (2013) (188)
Neurological and neuropshychological manifestations of HIV‐1 infection: Association with AIDS‐related complex but not asymptomatic HIV‐1 infection (1989) (187)
APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study (2013) (184)
Partial volume correction in quantitative amyloid imaging (2015) (182)
Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study (2013) (180)
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014 (2015) (175)
Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort (2010) (175)
Advanced cognitive training for breast cancer survivors: a randomized controlled trial (2012) (174)
Network approaches to systems biology analysis of complex disease: integrative methods for multi-omics data (2017) (173)
Slowly progressive aphasia without generalized dementia: Studies with positron emission tomography (1986) (172)
Breast cancer chemotherapy-related cognitive dysfunction. (2002) (162)
Event-Related Functional Magnetic Resonance Imaging of Response Inhibition in Obsessive-Compulsive Disorder (2007) (161)
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE (2015) (161)
Intact Motor Imagery in Chronic Upper Limb Hemiplegics: Evidence for Activity-Independent Action Representations (2002) (159)
Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease (2010) (156)
Memory deficits before and after temporal lobectomy: Effect of laterality and age of onset (1989) (155)
Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers (2013) (153)
Identifying quantitative trait loci via group-sparse multitask regression and feature selection: an imaging genetics study of the ADNI cohort (2012) (153)
Self- and informant reports of executive function on the BRIEF-A in MCI and older adults with cognitive complaints. (2006) (153)
Predictors of outcome after anterior temporal lobectomy (1994) (152)
Neuroimaging Findings in Mild Traumatic Brain Injury * (2001) (151)
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers (2018) (151)
The Relationship between fMRI Activation and Cerebral Atrophy: Comparison of Normal Aging and Alzheimer Disease (2000) (151)
Relations among clinical scales in schizophrenia. (1991) (151)
Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy. (2005) (149)
Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: Patterns of functional MRI activation (1999) (149)
Genetic architecture of subcortical brain structures in 38,851 individuals (2019) (148)
Impaired default network functional connectivity in autosomal dominant Alzheimer disease (2013) (146)
Functional differentiation of medial temporal and frontal regions involved in processing novel and familiar words: an fMRI study. (1999) (144)
Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity (2013) (143)
Language Before and After Temporal Lobectomy: Specificity of Acute Changes and Relation to Early Risk Factors (1995) (143)
Working memory deficits after traumatic brain injury: catecholaminergic mechanisms and prospects for treatment — a review (2004) (143)
Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease (2011) (142)
Identifying disease sensitive and quantitative trait-relevant biomarkers from multidimensional heterogeneous imaging genetics data via sparse multimodal multitask learning (2012) (140)
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
Sparse multi-task regression and feature selection to identify brain imaging predictors for memory performance (2011) (139)
APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern (2015) (138)
Genome-wide association study of the rate of cognitive decline in Alzheimer's disease (2014) (138)
Functional MRI localisation of central nervous system regions associated with volitional inspiration in humans (1999) (138)
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI) (2013) (137)
A noninvasive protocol for anterior temporal lobectomy (1992) (137)
Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (136)
Sex differences in semantic language processing: A functional MRI study (2003) (135)
Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? (2014) (135)
Altered default mode network connectivity in older adults with cognitive complaints and amnestic mild cognitive impairment. (2013) (134)
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults. (2016) (133)
Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage (2012) (133)
Increased brain activation during working memory in cognitively intact adults with the APOE ε4 allele (2006) (129)
Functional MRI of mild traumatic brain injury (mTBI): progress and perspectives from the first decade of studies (2012) (127)
Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection. (2013) (127)
Specific frontal lobe subregions correlated with unawareness of illness in schizophrenia: a preliminary study. (2001) (126)
Voxelwise gene-wide association study (vGeneWAS): Multivariate gene-based association testing in 731 elderly subjects (2011) (125)
A large scale multivariate parallel ICA method reveals novel imaging–genetic relationships for Alzheimer's disease in the ADNI cohort (2012) (125)
Apathy in schizophrenia: reduced frontal lobe volume and neuropsychological deficits. (2004) (119)
Visual contrast sensitivity in Alzheimer’s disease, mild cognitive impairment, and older adults with cognitive complaints (2013) (119)
Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia (2013) (118)
Executive dysfunction in attention-deficit/hyperactivity disorder: cognitive and neuroimaging findings. (2004) (117)
Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? (2013) (117)
Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers (2017) (117)
APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis (2014) (115)
Characteristics and variability of structural networks derived from diffusion tensor imaging (2012) (115)
Acute naming deficits following dominant temporal lobectomy (1990) (114)
Brain activation patterns associated with working memory in relapsing-remitting MS (2004) (111)
Adult neurogenesis and neurodegenerative diseases: A systems biology perspective (2017) (110)
Brain activation on fMRI and verbal memory ability: Functional neuroanatomic correlates of CVLT performance (2001) (110)
Occupational outcome after temporal lobectomy for refractory epilepsy (1995) (110)
GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP. (2015) (108)
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers (2019) (106)
Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases (2012) (104)
Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints (2006) (103)
Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. (2006) (103)
Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline (2017) (101)
Selective changes in white matter integrity in MCI and older adults with cognitive complaints. (2012) (101)
Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease (2013) (100)
Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports (2003) (99)
The fornix and mammillary bodies in older adults with Alzheimer's disease, mild cognitive impairment, and cognitive complaints: A volumetric MRI study (2006) (99)
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (96)
Regional reproducibility of pulsed arterial spin labeling perfusion imaging at 3T (2011) (95)
Comparison of Mesial Versus Neocortical Onset Temporal Lobe Seizures: Neurodiagnostic Findings and Surgical Outcome (1995) (95)
Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort (2010) (93)
Comparison of Manual and Automated Determination of Hippocampal Volumes in MCI and Early AD (2010) (92)
Neuropathological correlates and genetic architecture of microglial activation in elderly human brain (2018) (91)
Normative neuropsychological test performance: effects of age, education, gender and ethnicity. (1995) (90)
Cancer chemotherapy impairs contextual but not cue-specific fear memory (2007) (90)
Age-related deficits in fronto-temporal connections in schizophrenia: A diffusion tensor imaging study (2008) (90)
Analysis of Copy Number Variation in Alzheimer’s Disease in a Cohort of Clinically Characterized and Neuropathologically Verified Individuals (2012) (88)
Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. (2018) (88)
Neurological complications of human immunodeficiency virus infection in patients with lymphadenopathy syndrome (1988) (86)
A surface-based approach for classification of 3D neuroanatomic structures (2004) (86)
Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. (2020) (86)
Effect of Complement CR1 on Brain Amyloid Burden During Aging and Its Modification by APOE Genotype (2013) (84)
Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3–90 years (2021) (84)
Data mining in brain imaging (2000) (83)
COMT Val158Met Genotype and Individual Differences in Executive Function in Healthy Adults (2010) (82)
Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: A replication and extension study (2008) (82)
Patient Classification of fMRI Activation Maps (2003) (82)
Mild cognitive impairment: conceptual issues and structural and functional brain correlates. (2003) (81)
Structured sparse canonical correlation analysis for brain imaging genetics: an improved GraphNet method (2016) (81)
Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. (2006) (80)
Smaller brain size associated with unawareness of illness in patients with schizophrenia. (2000) (78)
Neuropsychological correlates of methylphenidate treatment in adult ADHD with and without depression. (1999) (78)
Clinical significance of sleep apnea in the elderly. (1987) (78)
The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests. (2016) (77)
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment (2013) (76)
International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients. (2018) (74)
Non-coding variability at the APOE locus contributes to the Alzheimer’s risk (2019) (74)
High-Order Multi-Task Feature Learning to Identify Longitudinal Phenotypic Markers for Alzheimer's Disease Progression Prediction (2012) (74)
Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease (2015) (74)
Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer’s disease (2018) (74)
Sparse Bayesian multi-task learning for predicting cognitive outcomes from neuroimaging measures in Alzheimer's disease (2012) (73)
Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis (2018) (73)
Decreased Cerebral Blood Flow in Chronic Pediatric Mild TBI: An MRI Perfusion Study (2015) (73)
The Alzheimer’s Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans (2015) (72)
APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba (2014) (72)
Functional microRNAs in Alzheimer’s disease and cancer: differential regulation of common mechanisms and pathways (2013) (71)
Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome (2020) (71)
Short Term Exposure to a Violent Video Game Induces Changes in Frontolimbic Circuitry in Adolescents (2009) (70)
Long-term seizure, cognitive, and psychiatric outcome following trans-middle temporal gyrus amygdalohippocampectomy and standard temporal lobectomy. (2013) (70)
Association of Blood Biomarkers With Acute Sport-Related Concussion in Collegiate Athletes (2020) (70)
Neuropsychological functioning in hemiparkinsonism (1989) (70)
Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking (2014) (70)
Polymorphisms in the brain-derived neurotrophic factor gene influence memory and processing speed one month after brain injury. (2012) (69)
Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns (2017) (69)
Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition (2019) (69)
The pattern of atrophy in familial Alzheimer disease (2013) (68)
Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort (2016) (68)
White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease (2018) (68)
Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations (2013) (67)
Genome-wide pathway analysis of memory impairment in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks (2012) (67)
Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer’s disease (2012) (66)
Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study. (2012) (66)
From phenotype to genotype: an association study of longitudinal phenotypic markers to Alzheimer's disease relevant SNPs (2012) (65)
Neuropsychological dysfunction in HIV-infection: Characterization in a lymphadenopathy cohort (1988) (65)
Identifying AD-Sensitive and Cognition-Relevant Imaging Biomarkers via Joint Classification and Regression (2011) (63)
Multiple loci influencing hippocampal degeneration identified by genome scan (2012) (63)
Influence of TSPO Genotype on 11C-PBR28 Standardized Uptake Values (2013) (63)
Neuropsychological Changes after Anterior Temporal Lobectomy Acute Effects on Memory, Language, and Music (1992) (62)
Multi-modal neuroimaging feature selection with consistent metric constraint for diagnosis of Alzheimer's disease (2019) (62)
Predictors of intellectual performance in adults with intractable temporal lobe epilepsy (1997) (62)
Effect of the dopamine D2 receptor T allele on response latency after mild traumatic brain injury. (2005) (60)
Effects of traumatic brain injury and posttraumatic stress disorder on development of Alzheimer's disease in Vietnam Veterans using the Alzheimer's Disease Neuroimaging Initiative: Preliminary report (2017) (60)
Optimization of seed density in DTI tractography for structural networks (2012) (60)
Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease (2017) (60)
The open diffusion data derivatives, brain data upcycling via integrated publishing of derivatives and reproducible open cloud services (2019) (60)
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans (2012) (59)
Neuropsychological impairment in borderline personality disorder. (2004) (59)
Genetic variants and functional pathways associated with resilience to Alzheimer’s disease (2020) (59)
Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study (2011) (59)
Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer’s Disease Neurodegeneration (2013) (58)
Longitudinal evaluation of neuropsychological function in homosexual men with HIV infection: 18-month follow-up. (1991) (58)
Neural organization of material-specific memory functions in temporal lobe epilepsy patients as assessed by the intracarotid amobarbital test. (1995) (58)
Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease (2017) (58)
Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: altered working memory and BOLD response. (2011) (57)
Identifying Neuroimaging and Proteomic Biomarkers for MCI and AD via the Elastic Net (2011) (57)
Greater male than female variability in regional brain structure across the lifespan (2020) (57)
Traumatic brain injury and age at onset of cognitive impairment in older adults (2016) (57)
Protective variant for hippocampal atrophy identified by whole exome sequencing (2015) (56)
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (56)
Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N=1198) using genome-wide search (2011) (56)
Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer’s disease in veterans, using the Alzheimer’s Disease Neuroimaging Initiative (2014) (55)
Functional magnetic resonance imaging of executive control in bipolar disorder (2006) (54)
Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer’s Disease (2020) (54)
Cognitive effects of cytotoxic cancer chemotherapy: Predisposing risk factors and potential treatments (2004) (54)
Identifying the Neuroanatomical Basis of Cognitive Impairment in Alzheimer's Disease by Correlation- and Nonlinearity-Aware Sparse Bayesian Learning (2014) (54)
Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer’s Disease (2020) (54)
Influence of Genetic Variation on Plasma Protein Levels in Older Adults Using a Multi-Analyte Panel (2013) (54)
The human connectome in Alzheimer disease — relationship to biomarkers and genetics (2021) (53)
Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease. (2017) (53)
Contribution of organizational strategy to verbal learning and memory in adults with attention-deficit/hyperactivity disorder. (2004) (53)
Cognitive complaints in older adults at risk for Alzheimer's disease are associated with altered resting-state networks (2016) (53)
Hippocampal shape analysis: surface-based representation and classification (2003) (53)
Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort (2011) (52)
The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (52)
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups (2018) (52)
Relationship between baseline brain metabolism measured using [18F]FDG PET and memory and executive function in prodromal and early Alzheimer’s disease (2012) (52)
Acute White-Matter Abnormalities in Sports-Related Concussion: A Diffusion Tensor Imaging Study from the NCAA-DoD CARE Consortium. (2017) (51)
Unilateral hemispheric memory and hippocampal neuronal density in temporal lobe epilepsy. (1993) (51)
MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties (2020) (50)
Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: Current status and recommendations for future research (2013) (50)
Dopaminergic challenge with bromocriptine one month after mild traumatic brain injury: altered working memory and BOLD response. (2011) (49)
Regional gray matter correlates of perceived emotional intelligence. (2011) (49)
Comparison of two short forms of the Wisconsin Card Sorting Test. (1991) (48)
Cavum septum pellucidum in schizophrenia: Clinical and neuropsychological correlates (2007) (48)
Memory during subclinical hippocampal seizures (1989) (48)
Acute effect of anterior temporal lobectomy on musical processing (1991) (48)
Proton spectroscopy in asymptomatic HIV-infected adults: initial results in a prospective cohort study. (1996) (47)
Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans. (2015) (47)
White matter alterations in early-stage Alzheimer's disease: A tract-specific study (2019) (47)
Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years (2021) (47)
Fully automated synthesis and initial PET evaluation of [11C]PBR28. (2009) (46)
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group (2016) (46)
Transcriptome-guided amyloid imaging genetic analysis via a novel structured sparse learning algorithm (2014) (46)
Increased working memory-related brain activity in middle-aged women with cognitive complaints (2013) (46)
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease (2020) (45)
Altered Cerebral Blood Flow One Month after Systemic Chemotherapy for Breast Cancer: A Prospective Study Using Pulsed Arterial Spin Labeling MRI Perfusion (2014) (44)
Progress in Polygenic Composite Scores in Alzheimer's and Other Complex Diseases. (2019) (44)
Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (44)
Cognitive functioning and neuroanatomic volume measures in schizophrenia. (1995) (44)
Age-at-Onset in Late Onset Alzheimer Disease is Modified by Multiple Genetic Loci (2014) (44)
Identification of associations between genotypes and longitudinal phenotypes via temporally-constrained group sparse canonical correlation analysis (2017) (43)
The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism (2016) (43)
Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study (2019) (42)
Reading on the Wide Range Achievement Test-Revised and parental education as predictors of IQ: comparison with the Barona formula (1995) (42)
Cortical surface biomarkers for predicting cognitive outcomes using group l 2,1 norm (2015) (42)
Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment (2016) (41)
Parametric surface modeling and registration for comparison of manual and automated segmentation of the hippocampus (2009) (41)
Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography (2017) (41)
Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study (2017) (41)
Differential lateralization of memory discrimination and response bias in temporal lobe epilepsy patients (1998) (41)
A Longitudinal Imaging Genetics Study of Neuroanatomical Asymmetry in Alzheimer’s Disease (2018) (40)
Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment☆ (2012) (40)
The Structural and Functional Connectome and Prediction of Risk for Cognitive Impairment in Older Adults (2015) (40)
Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts. (2013) (40)
Targeted metabolomics and medication classification data from participants in the ADNI1 cohort (2017) (39)
Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs (2019) (39)
Subjective rating of working memory is associated with frontal lobe volume in schizophrenia (2010) (39)
Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
A Survey of Neuropsychologists' Practices and Perspectives Regarding the Assessment of Judgment Ability (2008) (39)
A Novel Structure-Aware Sparse Learning Algorithm for Brain Imaging Genetics (2014) (38)
Association of plasma and cortical amyloid beta is modulated by APOE ε4 status (2014) (38)
Association of cancer history with Alzheimer's disease onset and structural brain changes (2014) (38)
Functional neuroanatomical correlates of episodic memory impairment in early phase psychosis (2016) (38)
Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial (2017) (38)
Topographic staging of tau positron emission tomography images (2018) (37)
Biological Hallmarks of Cancer in Alzheimer’s Disease (2019) (37)
Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates (2013) (36)
Gene-based GWAS and biological pathway analysis of the resilience of executive functioning (2014) (36)
Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease (2017) (36)
Genetically predicted body mass index and Alzheimer's disease–related phenotypes in three large samples: Mendelian randomization analyses (2015) (36)
The Interleukin 3 Gene (IL3) Contributes to Human Brain Volume Variation by Regulating Proliferation and Survival of Neural Progenitors (2012) (36)
Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral Neuropathy. (2016) (36)
Epigenome-wide meta-analysis of blood DNA methylation and its association with subcortical volumes: findings from the ENIGMA Epigenetics Working Group (2018) (35)
Decreased cancer survival in individuals separated at time of diagnosis (2009) (35)
Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging (2018) (35)
Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (35)
Identifying progressive imaging genetic patterns via multi-task sparse canonical correlation analysis: a longitudinal study of the ADNI cohort (2019) (34)
Increased brain activation during working memory processing after pediatric mild traumatic brain injury (mTBI). (2015) (34)
Large-scale genomics unveil polygenic architecture of human cortical surface area (2015) (34)
Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults. (2015) (34)
Detecting genetic associations with brain imaging phenotypes in Alzheimer's disease via a novel structured SCCA approach (2020) (34)
Cerebral blood flow in acute concussion: preliminary ASL findings from the NCAA-DoD CARE consortium (2019) (34)
Automatic Prediction of Conversion from Mild Cognitive Impairment to Probable Alzheimer's Disease using Structural Magnetic Resonance Imaging. (2010) (34)
Exercise prevents obesity-induced cognitive decline and white matter damage in mice (2019) (33)
Cognitive Dysfunction and Greater Visit‐to‐Visit Systolic Blood Pressure Variability (2013) (33)
Resting state network modularity along the prodromal late onset Alzheimer's disease continuum (2019) (33)
Loneliness and mental health during the COVID‐19 pandemic in older breast cancer survivors and noncancer controls (2021) (33)
Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology (2019) (33)
FASTKD2 is associated with memory and hippocampal structure in older adults (2014) (33)
A New Measure of Visual Location Learning and Memory: Development and Psychometric Properties for the Brown Location Test (BLT) (2007) (32)
A combined structural-functional classification of schizophrenia using hippocampal volume plus fMRI activation (2002) (32)
Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging (2016) (32)
Prevalence of Potentially Clinically Significant Magnetic Resonance Imaging Findings in Athletes with and without Sport-Related Concussion. (2019) (32)
Hippocampal Surface Mapping of Genetic Risk Factors in AD via Sparse Learning Models (2011) (32)
Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation (2017) (31)
Altered Brain Connectivity in Early Postmenopausal Women with Subjective Cognitive Impairment (2016) (31)
Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease (2020) (31)
Robust estimation of fractal measures for characterizing the structural complexity of the human brain: Optimization and reproducibility (2013) (31)
Genome-wide association and interaction studies of CSF T-tau/Aβ42 ratio in ADNI cohort (2017) (30)
Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. (2020) (30)
Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study (2018) (30)
Efficient Registration of 3D SPHARM Surfaces (2007) (30)
Reading on the Wide Range Achievement Test-Revised and parental education as predictors of IQ: comparison with the Barona formula. (1995) (30)
Deep learning detection of informative features in tau PET for Alzheimer’s disease classification (2020) (30)
Hippocampal Volume and Shape Analysis in an Older Adult Population (2007) (30)
Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N = 1345 young and elderly subjects (2012) (29)
Network-based analysis of genetic variants associated with hippocampal volume in Alzheimer’s disease: a study of ADNI cohorts (2016) (29)
Reliable change in neuropsychological assessment of breast cancer survivors (2016) (29)
Resting-state fMRI metrics in acute sport-related concussion and their association with clinical recovery: A study from the NCAA-DOD CARE Consortium. (2020) (29)
Task‐evoked functional connectivity does not explain functional connectivity differences between rest and task conditions (2018) (29)
Genetic Architecture of Subcortical Brain Structures in Over 40,000 Individuals Worldwide (2017) (28)
Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women. (2008) (28)
A novel SCCA approach via truncated ℓ1-norm and truncated group lasso for brain imaging genetics (2017) (28)
Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits (2016) (28)
FLAIR lesion volume in multiple sclerosis: Relation to processing speed and verbal memory (2005) (28)
Resting state network modularity along the prodromal late onset Alzheimer's disease continuum (2017) (27)
Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank (2020) (27)
Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study (2017) (27)
Detection of β-amyloid positivity in Alzheimer’s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers (2021) (27)
Multi-modal assessment in Alzheimer's disease. ADL in relation to PET, MRI and neuropsychology. (1995) (27)
Genetic pathway‐based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypes (2010) (27)
Serum triglycerides in Alzheimer disease (2020) (26)
Comparison of vertical and horizontal saccade measures and their relation to gray matter changes in premanifest and manifest Huntington disease (2012) (26)
Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau (2020) (26)
Longitudinal white-matter abnormalities in sports-related concussion (2020) (26)
Sparse Bayesian Learning for Identifying Imaging Biomarkers in AD Prediction (2010) (26)
Genetic Determinants of Cortical Structure (Thickness, Surface Area and Volumes) among Disease Free Adults in the CHARGE Consortium (2018) (26)
Targeted genetic analysis of cerebral blood flow imaging phenotypes implicates the INPP5D gene (2019) (26)
The Memory and Aging Telephone Screen: Development and preliminary validation (2007) (26)
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
Increased CNV-region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample. (2013) (26)
Fourier method for large-scale surface modeling and registration (2009) (25)
Genetic Interactions Explain Variance in Cingulate Amyloid Burden: An AV-45 PET Genome-Wide Association and Interaction Study in the ADNI Cohort (2015) (25)
Single-nucleotide polymorphisms are associated with cognitive decline at Alzheimer's disease conversion within mild cognitive impairment patients (2017) (25)
Genetic architecture of resilience of executive functioning (2012) (25)
Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease (2021) (25)
Neuroimaging, cancer, and cognition: state of the knowledge. (2013) (25)
Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors. (2019) (24)
Neurological symptoms and neuropsychological abnormalities in lymphadenopathy syndrome (1988) (24)
Clinical Use of Functional Magnetic Resonance Imaging: Reflections on the New CPT Codes (2007) (24)
Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer’s disease (2017) (24)
A Novel Surface Registration Algorithm With Biomedical Modeling Applications (2007) (24)
Hippocampal Sclerosis of Aging, a Common Alzheimer's Disease 'Mimic': Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe. (2016) (23)
Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease (2021) (22)
Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer's disease biomarker amyloid β1-42 in Alzheimer's Disease Neuroimaging Initiative participants (2017) (22)
Mood, stress and longevity: convergence on ANK3 (2016) (22)
Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer’s disease (2016) (22)
Cholinergic Enhancement of Brain Activation in Mild Cognitive Impairment during Episodic Memory Encoding (2013) (22)
Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living with Cancer Study. (2021) (22)
Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer (2018) (22)
Dementia of Parkinson's Disease and Alzheimer's Disease: Is There a Difference? (1986) (21)
Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease (2021) (21)
Intrinsic brain activity changes associated with adjuvant chemotherapy in older women with breast cancer: a pilot longitudinal study (2019) (21)
Memory concerns in the early Alzheimer's disease prodrome: Regional association with tau deposition (2018) (21)
Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer’s Disease (2016) (21)
Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: Interaction with genotype (2019) (21)
18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery (2018) (21)
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression. (2022) (20)
Apathy and the processing of novelty in schizophrenia (2008) (20)
Extraction of Discriminative Functional MRI Activation Patterns and an Application to Alzheimer's Disease (2004) (20)
Multi-Task Sparse Canonical Correlation Analysis with Application to Multi-Modal Brain Imaging Genetics (2019) (20)
Stability of MRI metrics in the advanced research core of the NCAA-DoD concussion assessment, research and education (CARE) consortium (2018) (20)
Development and validation of language and visuospatial composite scores in ADNI (2020) (20)
Morphometric Analysis of Hippocampal Shape in Mild Cognitive Impairment: An Imaging Genetics Study (2007) (20)
Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (20)
Resting state functional MRI in infants with prenatal opioid exposure—a pilot study (2020) (19)
Effects of chemotherapy on aging white matter microstructure: A longitudinal diffusion tensor imaging study. (2020) (19)
Similarities and Differences in Semantic and Phonological Processing with Age Patterns of Functional MRI Activation (2001) (19)
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease (2021) (19)
A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data (2019) (19)
Tissue‐specific network‐based genome wide study of amygdala imaging phenotypes to identify functional interaction modules (2017) (19)
Elevated cerebrospinal fluid tau protein concentrations on admission are associated with long-term neurologic and cognitive impairment in Ugandan children with cerebral malaria. (2019) (19)
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease (2020) (18)
Genome-wide association study of language performance in Alzheimer’s disease (2017) (18)
Interactive Machine Learning by Visualization: A Small Data Solution (2018) (18)
Identifying significant gene‐environment interactions using a combination of screening testing and hierarchical false discovery rate control (2016) (18)
Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot study (2010) (18)
Differences in Medication Use in the Alzheimer’s Disease Neuroimaging Initiative (2010) (18)
Age at injury is associated with the long-term cognitive outcome of traumatic brain injuries (2017) (18)
Dysregulated Fc gamma receptor–mediated phagocytosis pathway in Alzheimer's disease: network-based gene expression analysis (2019) (18)
Cerebral hypometabolism and grey matter density in MAPT intron 10 +3 mutation carriers. (2014) (18)
Prospective assessment of white matter integrity in adult stem cell transplant recipients (2016) (17)
Comparison of multi-sample variant calling methods for whole genome sequencing (2014) (17)
Deep brain stimulation in neuropsychiatric disorders (2001) (17)
Genome‐wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer's pathology (2020) (17)
Dysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI (2012) (17)
Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer’s disease (2015) (17)
Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways (2016) (16)
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status (2021) (16)
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status (2021) (16)
Identification of exon skipping events associated with Alzheimer’s disease in the human hippocampus (2018) (16)
Neurobehavioral studies in schizophrenia: implications for regional brain dysfunction. (1990) (16)
Neuroimaging in aging and neurologic diseases. (2019) (16)
Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition (2020) (16)
Identification of Discriminative Imaging Proteomics Associations in Alzheimer's Disease via a Novel Sparse Correlation Model> (2016) (16)
Genome‐wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways (2020) (16)
Lack of relationship between psychological denial and unawareness of illness in schizophrenia-spectrum disorders (2009) (16)
Association of peripheral blood DNA methylation level with Alzheimer’s disease progression (2021) (16)
Tau-related white-matter alterations along spatially selective pathways (2020) (16)
Associating Multi-Modal Brain Imaging Phenotypes and Genetic Risk Factors via a Dirty Multi-Task Learning Method (2020) (16)
Functional magnetic resonance imaging of the primary somatosensory cortex in piglets. (2006) (16)
Judgment in Older Adults with Normal Cognition, Cognitive Complaints, MCI, and Mild AD: Relation to Regional Frontal Gray Matter (2009) (16)
Serum triglycerides in Alzheimer’s disease: Relation to neuroimaging and CSF biomarkers (2018) (15)
Telomere length associations with cognition depend on Alzheimer's disease biomarkers (2019) (15)
Imaging genomics discovery of a new risk variant for Alzheimer's disease in the postsynaptic SHARPIN gene (2020) (15)
Cortical Thickness Trajectories across the Lifespan: Data from 17,075 healthy individuals aged 3-90 years (2020) (15)
Joint High-Order Multi-Task Feature Learning to Predict the Progression of Alzheimer's Disease (2018) (15)
[Accepted Manuscript] Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study. (2017) (15)
Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease. (2011) (15)
Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort (2017) (15)
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease (2018) (15)
Two-dimensional enrichment analysis for mining high-level imaging genetic associations (2016) (15)
Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (15)
A New Sparse Simplex Model for Brain Anatomical and Genetic Network Analysis (2013) (14)
Assembly of 809 whole mitochondrial genomes with clinical, imaging, and fluid biomarker phenotyping (2018) (14)
Fast Multi-Task SCCA Learning with Feature Selection for Multi-Modal Brain Imaging Genetics (2018) (14)
Association between size of the lateral ventricle and asymmetry of the fornix in patients with temporal lobe epilepsy. (1998) (14)
The Impact of Using Different Reference Populations on Measurement of Breast Cancer-Related Cognitive Impairment Rates (2018) (14)
Assessment of Blood Biomarker Profile After Acute Concussion During Combative Training Among US Military Cadets (2021) (13)
Do Candidate Genes Affect the Brain’s White Matter Microstructure? Large-Scale Evaluation of 6,165 Diffusion MRI Scans (2017) (13)
Unified representation of tractography and diffusion-weighted MRI data using sparse multidimensional arrays (2017) (13)
PATHWAY LEVEL CODON BIAS AMONG SYNONYMOUS RARE VARIANTS IS ASSOCIATED WITH ALZHEIMER’S DISEASE IMAGING BIOMARKER (2018) (13)
Exploring Interestingness in a Computational Evolution System for the Genome-Wide Genetic Analysis of Alzheimer's Disease (2013) (13)
Hippocampal transcriptome-guided genetic analysis of correlated episodic memory phenotypes in Alzheimer's disease (2015) (13)
Neurocognitive Dimensions of Breast Cancer and Its Treatment (2011) (13)
Exome Chip Analysis Identifies Low-Frequency and Rare Variants in MRPL38 for White Matter Hyperintensities on Brain Magnetic Resonance Imaging (2018) (13)
The effect of reference panels and software tools on genotype imputation. (2011) (13)
Building a surface atlas of hippocampal subfields from MRI scans using FreeSurfer, FIRST and SPHARM (2014) (13)
Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau (2020) (13)
GN-SCCA: GraphNet Based Sparse Canonical Correlation Analysis for Brain Imaging Genetics (2015) (13)
Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer’s disease (2017) (13)
Brain Imaging and Behavior: Progress and Opportunities (2007) (13)
MetaDL: A Digital Library of Metadata for Sensitive or Complex Research Data (2002) (13)
The Association Between Persistent White-Matter Abnormalities and Repeat Injury After Sport-Related Concussion (2020) (13)
Cognitive function prior to systemic therapy and subsequent well‐being in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Study (2020) (12)
Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study (2021) (12)
Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study (2021) (12)
Identifying Associations Between Brain Imaging Phenotypes and Genetic Factors via a Novel Structured SCCA Approach (2017) (12)
Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding (2015) (12)
A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease (2016) (12)
Genome-wide analysis reveals novel genes in fl uencing temporal lobe structure with relevance to neurodegeneration in Alzheimer ' s disease (2010) (12)
Identifying diagnosis-specific genotype–phenotype associations via joint multitask sparse canonical correlation analysis and classification (2020) (12)
Morphometric Analysis of Brain Structures for Improved Discrimination (2003) (12)
Cognition and Cancer: Brain imaging investigation of chemotherapy-induced neurocognitive changes (2008) (12)
Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer’s disease neuroimaging initiative (2017) (12)
Subcortical Volume Trajectories across the Lifespan: Data from 18,605 healthy individuals aged 3-90 years (2020) (12)
A Graph-Based Integration of Multimodal Brain Imaging Data for the Detection of Early Mild Cognitive Impairment (E-MCI) (2013) (12)
Volumetric comparison of hippocampal subfields extracted from 4-minute accelerated vs. 8-minute high-resolution T2-weighted 3T MRI scans (2018) (11)
Metamemory in Temporal Lobe Epilepsy (1996) (11)
Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort. (2019) (11)
Injection of air bubbles during flushing of angiocatheters: an in vitro trial of conventional hardware and techniques. (2001) (11)
Genome-wide Network-assisted Association and Enrichment Study of Amyloid Imaging Phenotype in Alzheimer's Disease. (2019) (11)
Regional imaging genetic enrichment analysis (2019) (11)
Genetic Clustering on the Hippocampal Surface for Genome-Wide Association Studies (2013) (11)
Neuroimaging in Infants with Prenatal Opioid Exposure: Current Evidence, Recent Developments and Targets for Future Research. (2020) (11)
Applying a Life Course Biological Age Framework to Improving the Care of Individuals With Adult Cancers: Review and Research Recommendations. (2021) (11)
An interactive user interface system for Alzheimer's intervention (2010) (11)
Genetic variation affecting exon skipping contributes to brain structural atrophy in Alzheimer’s disease (2018) (11)
Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis (2020) (11)
FMRI wada test: Prospects for presurgical mapping of language and memory (2010) (11)
Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [18F]Flortaucipir PET (2018) (10)
Human Connectome Module Pattern Detection Using a New Multi-graph MinMax Cut Model (2014) (10)
Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts (2019) (10)
Quantitative trait loci identification for brain endophenotypes via new additive model with random networks (2018) (10)
Deep Learning in Alzheimer's Disease: Diagnostic Classification using Neuroimaging Data (2019) (10)
Externalizing personality traits, empathy, and gray matter volume in healthy young drinkers (2016) (10)
Longitudinal Genotype-Phenotype Association Study via Temporal Structure Auto-learning Predictive Model (2017) (10)
“behavioral imaging”—III. Interexpert agreement and reliability of weightings (1990) (10)
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives (2021) (10)
A novel deep learning method for predictive modeling of microbiome data (2020) (10)
Classification and Mining of Brain Image Data Using Adaptive Recursive Partitioning Methods: Application to Alzheimer Disease and Brain Activation Patterns (2003) (10)
Apathy Is Associated With Ventral Striatum Volume in Schizophrenia Spectrum Disorder. (2016) (10)
Identification of functional variants from whole-exome sequencing, combined with neuroimaging genetics (2013) (10)
Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians. (2015) (10)
Towards Subject and Diagnostic Identifiability in the Alzheimer's Disease Spectrum Based on Functional Connectomes (2018) (10)
Rare variants in the splicing regulatory elements of EXOC3L4 are associated with brain glucose metabolism in Alzheimer’s disease (2018) (10)
The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum (2016) (10)
Structured sparse CCA for brain imaging genetics via graph OSCAR (2016) (10)
Shape-based discriminative analysis of combined bilateral hippocampi using multiple object alignment (2004) (10)
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease (2022) (9)
Optimizing differential identifiability improves connectome predictive modeling of cognitive deficits from functional connectivity in Alzheimer's disease (2021) (9)
FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2020) (9)
Subcortical brain iron deposition and cognitive performance in older women with breast cancer receiving adjuvant chemotherapy: A pilot MRI study. (2018) (9)
“Behavioral imaging”―a procedure for analysis and display of neuropsychological test scores: I. construction of algorithm and initial clinical evaluation (1988) (9)
Diagnosis Status Guided Brain Imaging Genetics Via Integrated Regression And Sparse Canonical Correlation Analysis (2019) (9)
Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease (2021) (9)
FASTKD2 and human memory: functional pathways and prospects for novel therapeutic target development for Alzheimer's disease and age-associated memory decline. (2015) (9)
Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression (2021) (9)
Novel Markers of Angiogenesis in the Setting of Cognitive Impairment and Dementia. (2020) (9)
Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease (2022) (9)
Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease (2022) (9)
Network-Guided Sparse Learning for Predicting Cognitive Outcomes from MRI Measures (2013) (8)
Morphometric MRI study of hippocampal shape in MCI using spherical harmonics (2005) (8)
Identifying Connectome Module Patterns via New Balanced Multi-graph Normalized Cut (2015) (8)
MORPHOMETRIC ANALYSIS OF GENETIC VARIATION IN HIPPOCAMPAL SHAPE IN MILD COGNITIVE IMPAIRMENT : ROLE OF AN IL-6 PROMOTER POLYMORPHISM (2006) (8)
Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum (2021) (8)
Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer’s disease subgroups (2021) (8)
Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty (2017) (8)
A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease (2020) (8)
Neurologic injury associated with CABG surgery: outcomes, mechanisms, and opportunities for improvement. (2004) (8)
Frontal and hippocampal memory circuitry in early Alzheimer's disease: Relation of structural and functional MRI changes (2000) (8)
A missense variant in SHARPIN mediates Alzheimer’s disease-specific brain damages (2021) (8)
Structural Brain Network Constrained Neuroimaging Marker Identification for Predicting Cognitive Functions (2013) (8)
Data synthesis and method evaluation for brain imaging genetics (2014) (8)
Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease (2021) (8)
Multiple incomplete views clustering via non-negative matrix factorization with its application in Alzheimer's disease analysis (2018) (8)
A Systematic Review of Delirium Biomarkers and Their Alignment with the NIA‐AA Research Framework (2020) (8)
Sparse Canonical Correlation Analysis via truncated ℓ1-norm with application to brain imaging genetics (2016) (8)
Differential sensitivity of cognitive complaints associated with amnestic MCI: Analysis of patient and informant reports (2005) (8)
Optimizing Differential Identifiability Improves Connectome Predictive Modeling of Cognitive Deficits in Alzheimer\'s Disease (2019) (8)
Principal components analysis of hippocampal shape in schizophrenia (2003) (8)
The role of visualization and 3-D printing in biological data mining (2015) (8)
Translational research on aging: clinical epidemiology as a bridge between the sciences. (2014) (8)
Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease: Results of the DIAN Study (2015) (8)
Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization (2021) (7)
Surface-based morphometric analysis of hippocampal subfields in mild cognitive impairment and Alzheimer's disease (2015) (7)
Management of Chemotherapy-Related Cognitive Dysfunction (2007) (7)
Functional magnetic resonance imaging: Emerging clinical applications (2002) (7)
Latent Classes of Cognitive Functioning Among Depressed Older Adults Without Dementia (2019) (7)
Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors (2021) (7)
The neuropsychology of multiple sclerosis: Contributions of neuroimaging research (2001) (7)
Predicting Interrelated Alzheimer's Disease Outcomes via New Self-learned Structured Low-Rank Model (2017) (7)
Designing the next-generation clinical care pathway for Alzheimer’s disease (2022) (7)
Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer’s disease (2021) (7)
Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer’s disease (2021) (7)
Neurodegenerative Patterns of Cognitive Clusters of Early-Onset Alzheimer’s Disease Subjects: Evidence for Disease Heterogeneity (2020) (7)
Brain-wide structural connectivity alterations under the control of Alzheimer risk genes. (2020) (7)
Integrated Visualization of Human Brain Connectome Data (2015) (7)
Association of blood-based transcriptional risk scores with biomarkers for Alzheimer disease (2020) (7)
Predictive metabolic networks reveal sex‐ and APOE genotype‐specific metabolic signatures and drivers for precision medicine in Alzheimer's disease (2022) (7)
Multimodal Neuroimaging Predictors for Cognitive Performance Using Structured Sparse Learning (2012) (7)
PARP1 Gene Variation and Microglial Activity on [11C]PBR28 PET in Older Adults at Risk for Alzheimer's Disease (2013) (7)
Diagnosis-Guided Method for Identifying Multi-Modality Neuroimaging Biomarkers Associated with Genetic Risk Factors in Alzheimer's Disease (2016) (7)
[(11)C]PiB PET in Gerstmann-Sträussler-Scheinker disease. (2016) (7)
Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. (2022) (6)
Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease (2022) (6)
Multi-task learning based structured sparse canonical correlation analysis for brain imaging genetics (2021) (6)
Predicting progressions of cognitive outcomes via high-order multi-modal multi-task feature learning (2018) (6)
How Will Aducanumab Approval Impact AD Research? (2021) (6)
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2018) (6)
Identical twins with probable alzheimer’s disease: Behavior, anatomy, and physiology (1988) (6)
Effect of chemotherapy on default mode network connectivity in older women with breast cancer (2021) (6)
Computational genetics analysis of grey matter density in Alzheimer’s disease (2014) (6)
Cognitive complaints are associated with smaller right medial temporal gray-matter volume in younger postmenopausal women (2020) (6)
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4 (2022) (6)
Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume (2022) (6)
Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (6)
Association of Plasma Tau With Mortality and Long-term Neurocognitive Impairment in Survivors of Pediatric Cerebral Malaria and Severe Malarial Anemia (2021) (6)
Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group (2016) (6)
Longitudinal Genotype-Phenotype Association Study through Temporal Structure Auto-Learning Predictive Model (2018) (6)
Alpha-synuclein (SNCA) polymorphisms exert protective effects on memory after mild traumatic brain injury (2016) (6)
Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID‐19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study (2022) (6)
APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies (2022) (6)
Dementias and neurodegenerative diseases. (2014) (5)
Morphometric Analysis of 3 D Surfaces : Application to Hippocampal Shape in Mild Cognitive Impairment (2005) (5)
Memory activation in schizophrenia: Preliminary observations using functional magnetic resonance imaging (fMRI ) (1995) (5)
An Integrated Molecular Atlas of Alzheimer's Disease (2021) (5)
Systems modeling of white matter microstructural abnormalities in Alzheimer's disease (2020) (5)
Heritability Estimation of Reliable Connectomic Features (2018) (5)
The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (5)
Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer’s disease (2021) (5)
Transcriptome-Guided Imaging Genetic Analysis via a Novel Sparse CCA Algorithm (2017) (5)
Volumetric GWAS of medial temporal lobe structures identifies an ERC1 locus using ADNI high-resolution T2-weighted MRI data (2020) (5)
Rare CASP6N73T variant associated with hippocampal volume exhibits decreased proteolytic activity, synaptic transmission defect, and neurodegeneration (2021) (5)
Spatial comparison of fMRI activation maps for data mining (2001) (5)
Identification of functionally connected multi-omic biomarkers for Alzheimer’s disease using modularity-constrained Lasso (2019) (5)
Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions (2020) (5)
Neuroinflammation and amyloid deposition: Concurrent [11C]PBR28 and [11C]PIB PET imaging in patients with Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints (2010) (5)
MIND food and speed of processing training in older adults with low education, the MINDSpeed Alzheimer's disease prevention pilot trial. (2019) (5)
Multivariate genome wide association and network analysis of subcortical imaging phenotypes in Alzheimer’s disease (2020) (5)
Psychological and Psychosocial Outcome of Anterior Temporal Lobectomy (1992) (5)
Associations Between Depression, Traumatic Brain Injury, and Cognitively-Defined Late-Onset Alzheimer's Disease Subgroups. (2019) (5)
P2-077: Comparison of manual and automated determination of hippocampal volumes in MCI and older adults with cognitive complaints (2008) (5)
Identifying Candidate Genetic Associations with MRI-Derived AD-Related ROI via Tree-Guided Sparse Learning (2019) (5)
Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study (2021) (5)
DNA METHYLATION DYNAMICS IN ALZHEIMER’S DISEASE DIAGNOSIS AND PROGRESSION (2017) (5)
The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life Depression. (2021) (5)
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease (2022) (5)
Task-Evoked Functional Connectivity Does Not Explain Functional Connectivity Differences Between Rest and Task Conditions (2018) (4)
Neuroimaging of Alzheimer’s Disease, Mild Cognitive Impairment, and Other Dementias (2011) (4)
Accelerating Sparse Canonical Correlation Analysis for Large Brain Imaging Genetics Data (2014) (4)
Association of plasma and cortical beta-amyloid is modulated by APOE ε4 status. (2014) (4)
Novel genomic loci and pathways influence patterns of structural covariance in the human brain (2022) (4)
Genome-wide association reveals dopamine-related genetic effects on caudate volume (2011) (4)
Cognitively stimulating environments and cognitive reserve: the case of personal social networks (2022) (4)
Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment (2021) (4)
“behavioral imaging”: II. Application of the quantitative algorithm to hypothesistesting in a population ofhemiparkinsonian patients (1988) (4)
Functional MRI Studies of Memory in Aging, Mild Cognitive Impairment, and Alzheimer’s Disease (2011) (4)
The Meyers article reviewed (2000) (4)
Genetic data and cognitively-defined late-onset Alzheimer’s disease subgroups (2018) (4)
Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 (2022) (4)
Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes (2021) (4)
Head injury is associated with tau deposition on PET in MCI and AD patients (2021) (4)
KLK8 AS A MODULATOR OF ALZHEIMER’S DISEASE PATHOLOGY: NEUROIMAGING GENETICS (2017) (4)
COGNITIVE COMPLAINTS IN OLDER ADULTS AT RISK FOR ALZHEIMER’S DISEASE ARE ASSOCIATED WITH ALTERED RESTING STATE NETWORKS (2016) (4)
The Alzheimer’s Disease Metabolome: Effects of Sex and APOE ε4 genotype (2019) (4)
Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (4)
Multigraph Visualization for Feature Classification of Brain Network Data (2016) (4)
Integrative-omics for discovery of network-level disease biomarkers: a case study in Alzheimer's disease. (2021) (4)
Mapre2 as a novel Alzheimer's disease target gene from gwas of CSF amyloid beta 1-42, tau and hyperphosphorylated tau in the ADNI cohort (2015) (4)
Identifying differences in bile acid pathways for cholesterol clearance in Alzheimer’s disease using metabolic networks of human brain regions (2019) (3)
Longitudinal analysis of UK Biobank participants suggests age and APOE-dependent alterations of energy metabolism in development of dementia (2022) (3)
Mining Regional Imaging Genetic Associations via Voxel-wise Enrichment Analysis (2019) (3)
Neuroimaging Advances in Neurologic and Neurodegenerative Diseases (2021) (3)
ALTERED BILE ACID METABOLITES IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE: RELATION TO NEUROIMAGING AND CSF BIOMARKERS (2018) (3)
A TOPOGRAPHIC IMAGING BIOMARKER OF TDP43 PATHOLOGY IN AMNESTIC DEMENTIA BASED ON AUTOPSY-DERIVED FDG-PET PATTERNS (2019) (3)
Traumatic brain injury and post‐traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers (2022) (3)
Preoperative functional mapping using intracranial EEG activation methods. (2000) (3)
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (3)
Social Networks and Cognitive Reserve: Network Structure Moderates the Association between Amygdalar Volume and Cognitive Outcomes. (2021) (3)
APOE effect on Alzheimer’s biomarkers in older adults with significant memory concern (2015) (3)
Brain explorer for connectomic analysis (2017) (3)
Characterization of regional cerebral blood flow in mild cognitive impairment and older adults with cognitive complaints (2013) (3)
Age-related neuroinflammation in non-demented elderly adults: Preliminary findings with the TSPO ligand [11C]PBR28 (2010) (3)
Cognitive domain harmonization and cocalibration in studies of older adults. (2022) (3)
Genetic predictors of 12-month change in MRI hippocampal volume in the Alzheimer's Disease Neuroimaging Initiative cohort: Analysis of leading candidates from the AlzGene database (2009) (3)
Working memory in multiple sclerosis: Relation of fMRI activation to lesion volume (2001) (3)
Cognitive Dysfunction is Associated with Increased Visit to Visit Systolic Blood Pressure Variability (2014) (3)
FOURIER METHODS FOR 3D SURFACE MODELING AND ANALYSIS (2011) (3)
Alterations in metabolic pathways and networks in mild cognitive impairment and early Alzheimer's disease (2013) (3)
Altered cerebral blood flow in older adults with Alzheimer’s disease: a systematic review (2022) (3)
Testing for Laterality Differences in Regional Brain Volumes (2000) (3)
Principles and Practice of Lifespan Developmental Neuropsychology: Structural and functional neuroimaging throughout the lifespan (2010) (3)
Relationship of microglial activation measured by [11C]PBR28 PET, atrophy on MRI and plasma biomarkers in individuals with and at risk for Alzheimer's disease (2013) (3)
Differential diagnosis of amnestic dementia patients based on an FDG‐PET signature of autopsy‐confirmed LATE‐NC (2022) (3)
Hippocampal subfield atrophy on 3T MRI in prodromal Alzheimer's disease and older adults with cognitive complaints (2012) (3)
Genetic, clinical underpinnings of subtle early brain change along Alzheimer’s dimensions (2022) (3)
Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Cholesterol Metabolism in Alzheimer’s Disease (2020) (3)
Visual exploration of genetic association with voxel-based imaging phenotypes in an MCI/AD study (2009) (3)
Relationship between baseline brain metabolism measured using [18F]FDG PET and memory and executive function in prodromal and early Alzheimer’s disease (2012) (3)
Differential trajectories of hypometabolism across cognitively-defined Alzheimer’s disease subgroups (2021) (3)
Cognitive biomarker prioritization in Alzheimer’s Disease using brain morphometric data (2020) (3)
Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy (2022) (3)
430 Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: A meta-analytic study (1997) (3)
EVALUATION METRICS FOR USER-CENTERED RANKING OF CONTENT IN METADLs (2004) (3)
Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease (2020) (3)
A system framework for the integration and analysis of multi-modal spatiotemporal data streams: a case study in MS lesion analysis (2003) (3)
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics (2022) (3)
Surface-based Morphometric Analysis for Hippocampal Shape in Schizophrenia (3)
Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment (2022) (3)
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (3)
Data synthesis and tool development for exploring imaging genomic patterns (2009) (3)
BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease (2021) (3)
Stability of Subjective Executive Functioning in Older Adults with aMCI and Subjective Cognitive Decline. (2021) (3)
Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative (2021) (3)
Targeted lipidomic pathway-guided genetic association with Alzheimer's disease–relevant endophenotypes (2013) (2)
Genome-wide association study of brain arteriolosclerosis (2022) (2)
Determination of Regional Cerebral Function and Structure in Normal Aging and Dementia with Positron Emission Tomography, Magnetic Resonance Imaging and X-Ray Computed Tomography (1986) (2)
Genetic findings using ADNI multimodal quantitative phenotypes: A 2014 update (2015) (2)
Joint identification of imaging and proteomics biomarkers of Alzheimer's disease using network-guided sparse learning (2014) (2)
DNA damage in peripheral blood cells is associated with Alzheimer's disease (AD)-related plasma proteins in individuals at risk for progression to AD (2013) (2)
Music Cognition in Breast Cancer Survivors (2011) (2)
Nervous system sequelae of chemotherapy treatment: Associations and proposed mechanisms. (2014) (2)
Medical Care Disruptions During the First Six-Months of the COVID19 Pandemic: The Experience of Older Breast Cancer Survivors (2021) (2)
ARE WHITE MATTER HYPERINTENSITIES A CORE FEATURE OF ALZHEIMER’S DISEASE OR JUST A REFLECTION OF AMYLOID ANGIOPATHY? EVIDENCE FROM THE DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN) (2016) (2)
Functional MRI Localization of CNS Regions Associated with Volitional Inspiration (1998) (2)
Sex‐associated differences in pathology burden in early‐onset Alzheimer’s disease (2020) (2)
Joint exploration and mining of memory-relevant brain anatomic and connectomic patterns via a three-way association model (2018) (2)
MULTIMODAL-CNN: IMPROVED ACCURACY OF MRI-BASED CLASSIFICATION OF ALZHEIMER’S DISEASE BY INCORPORATING CLINICAL DATA IN DEEP LEARNING (2018) (2)
Cognition in older breast cancer patients prior to systemictherapy: The Thinking and Living With Cancer (TLC) study (2013) (2)
Building a surface atlas of hippocampal subfields from high resolution T2-weighted MRI scans using landmark-free surface registration (2016) (2)
Deep learning-based identification of genetic variants: Application to Alzheimer's disease classification (2021) (2)
Identifying highly heritable brain amyloid phenotypes through mining Alzheimer’s imaging and sequencing biobank data (2021) (2)
Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease (2020) (2)
Hippocampus as a Predictor of Cognitive Performance : Comparative Evaluation of Analytical Methods and Morphometric Measures (2012) (2)
Response to yeo et al.'s critique of behavioral imaging (1990) (2)
Imaging genetics of the SPON1 gene variant rs11023139 in Alzheimer's disease (2013) (2)
Serum Metabolites Associated with Brain Amyloid Beta Deposition, Cognitive Dysfunction, and Alzheimer’s Disease Progression (2020) (2)
Re-evaluation of psychometric evidence and update of normative data for the Test of Practical Judgment (2021) (2)
Investigating the importance of acylcarnitines in Alzheimer’s disease (2021) (2)
MULTIMODAL-3DCNN: DIAGNOSTIC CLASSIFICATION OF ALZHEIMER’S DISEASE USING DEEP LEARNING ON NEUROIMAGING, GENETIC, AND DEMOGRAPHIC DATA (2019) (2)
MULTIVARIATE CLUSTER PROFILING OF AMYLOID BETA, TAU, NEURODEGENERATION AND VASCULAR (ATNV) BIOMARKERS IN THE ADNI COHORT: IMPLICATIONS FOR COGNITION, –OMICS AND CLINICAL TRIALS (2018) (2)
The formation of the advisory group on risk evaluation education for dementia (2020) (2)
Stimulus tracking in functional magnetic resonance imaging (fMRI) (1998) (2)
SOCIAL NETWORKS AND COGNITIVE PERFORMANCE IN OLDER ADULTS WITH NORMAL COGNITION, MILD COGNITIVE IMPAIRMENT, AND MILD ALZHEIMER’S DISEASE (2017) (2)
IL-6 allelic variation and medial temporal morphology in MCI and older adults with memory complaints (2005) (2)
IC-P2-132: Hippocampal and distributed gray matter abnormalities in MCI and early AD in the ADNI baseline 1.5T MRI scans: Cross-sectional analysis and relation to verbal learning (2008) (2)
Cerebral blood flow in acute concussion: preliminary ASL findings from the NCAA-DoD CARE consortium (2018) (2)
A New Statistical Image Analysis Approach and Its Application to Hippocampal Morphometry (2016) (2)
Self- versus informant-based cognitive complaints: Relation of E-Cog scores to imaging, biomarkers and clinical Status in ADNI-2 (2013) (2)
Elevated PiB precedes dementia in autosomal dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort (2012) (2)
Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: Current status and recommendations for future research (2013) (2)
Genome-wide meta-analyses reveal novel loci for verbal short-term memory and learning (2022) (2)
Characterizing Gene and Protein Crosstalks in Subjects at Risk of Developing Alzheimer’s Disease: A New Computational Approach (2017) (2)
Characterization of neuropsychological dysfunction in schizophrenia: Relation to clinical subtypes and positive and negative features (1990) (2)
Prioritization of Cognitive Assessments in Alzheimer's Disease via Learning to Rank using Brain Morphometric Data (2019) (2)
Influence of rare reelin variants on quantitative PET imaging and CSF phenotypes in late-onset Alzheimer’s disease (2015) (2)
Functional Magnetic Resonance Imaging (1996) (2)
Differential Effects of Pergolide and Bromocriptine on Working Memory Performance and Brain Activation after Mild Traumatic Brain Injury (MTBI). (2020) (2)
Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study (2022) (2)
IMPROVING PREDICTION OF COGNITIVE OUTCOMES FROM FUNCTIONAL CONNECTIVITY IN ALZHEIMER’S DISEASE (2019) (2)
Genome-wide rare variant analysis identifies candidate genes significantly associated with composite scores for memory (2015) (2)
Altered connectome mapping in mild cognitive impairment and older adults with cognitive complaints (2013) (2)
Low-cost method of presenting visual stimuli during MR. (1995) (2)
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data (2014) (2)
Pre-treatment psychoneurological symptoms and their association with longitudinal cognitive function and quality of life in older breast cancer survivors (2018) (2)
Planar cell polarity pathway and development of the human visual cortex (2018) (2)
BIN1 AND CR1 VARIANTS AFFECT COGNITIVE PERFORMANCE, NEURODEGENERATION, AND BRAIN AMYLOIDOSIS IN ADNI SUBJECTS (2014) (2)
Pattern Visualization of Human Connectome Data (2012) (2)
Structural, functional and molecular imaging as intermediate phenotypes for studies of candidate genes, pathways and GWAS in Alzheimer's disease (2012) (2)
Correction: Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups (2019) (2)
Identifying imaging genetic associations via regional morphometricity estimation (2021) (1)
A/T/N polygenic risk score for cognitive decline in old age (2019) (1)
Progressive white matter abnormalities in autosomal dominant Alzheimer's disease: Results of the DIAN study (2012) (1)
Estradiol treatment in young postmenopausal women with self‐reported cognitive complaints: Effects on cholinergic‐mediated cognitive performance (2022) (1)
A novel MRI contrast weighted ratio method for measuring myelin in older adults at risk for Alzheimer’s disease (2020) (1)
Integrative Co-methylation Network Analysis Identifies Novel DNA Methylation Signatures and Their Target Genes in Alzheimer’s Disease (2022) (1)
Erratum to: Traumatic brain injury and age at onset of cognitive impairment in older adults (2016) (1)
ALTERED FMRI ACTIVATION PATTERN DURING VISUAL SCENE ENCODING IN AFFECTED AND NON-AFFECTED CARRIERS OF PSEN1 AND APP MUTATIONS (2014) (1)
Genome‐wide study of the human lipidome and links to Alzheimer’s disease risk (2020) (1)
Multi-task deep autoencoder to predict Alzheimer’s disease progression using temporal DNA methylation data in peripheral blood (2022) (1)
COGNITIVELY DEFINED SUBTYPES OF ALZHEIMER’S DISEASE ARE ASSOCIATED WITH DISTINCT PATTERNS OF ATROPHY (2018) (1)
S32. ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS POTENTIAL THERAPEUTICS FOR SCHIZOPHRENIA? (2020) (1)
Reply: To PMID 25559091. (2015) (1)
SUBTYPES OF NEURODEGENERATION IN ALZHEIMER DISEASE: A HEAD-TO-HEAD COMPARISON OF FOUR BRAIN ATROPHY SUBTYPE ALGORITHMS IN ADNI (2018) (1)
Prioritizing Amyloid Imaging Biomarkers in Alzheimer's Disease via Learning to Rank (2019) (1)
Author Correction: Rare CASP6N73T variant associated with hippocampal volume exhibits decreased proteolytic activity, synaptic transmission defect, and neurodegeneration (2021) (1)
Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease (2021) (1)
Computational genetics analysis of grey matter density in Alzheimer’s disease (2014) (1)
Relationship between CSF and plasma proteomic data in the ADNI-1 cohort (2012) (1)
Six‐month decline in language, but not other cognitive domains, identifies increased risk of conversion from MCI to AD in ADNI (2020) (1)
New Probabilistic Multi-graph Decomposition Model to Identify Consistent Human Brain Network Modules (2016) (1)
Decreased gray matter volume in postmenopausal women who report cognitive complaints (2013) (1)
A Fast SCCA Algorithm for Big Data Analysis in Brain Imaging Genetics (2017) (1)
IC-P1-054: Comparison of manual and automated determination of hippocampal volumes in MCI and older adults with cognitive complaints (2008) (1)
GPU Accelerated Browser for Neuroimaging Genomics (2018) (1)
Genetic architecture of subcortical brain structures in 38,851 individuals (2019) (1)
Prevalence and growth of cerebral microhemorrhages in autosomal dominant Alzheimer's disease (2013) (1)
A Dirty Multi-task Learning Method for Multi-modal Brain Imaging Genetics (2019) (1)
White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantlyinherited Alzheimer’s disease (2018) (1)
Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2021) (1)
Abstract A012: Differences in attention, processing speed, and executive function in older breast cancer survivors compared to controls is partially explained by plasma IL-6: The Thinking and Living with Cancer (TLC) Study (2023) (1)
MICRORNA AND GENE NETWORKS UNDERLYING THE INVERSE ASSOCIATION OF CANCER AND ALZHEIMER’S DISEASE (2017) (1)
EXAMINING THE EFFECT OF THE TOP 20 ALZHEIMER'S DISEASE RISK VARIANTS ON BRAIN AMYLOIDOSIS, STRUCTURAL ATROPHY AND METABOLISM (2016) (1)
CEREBROSPINAL FLUID LEVELS OF AMYLOID BETA AND TAU AS ENDOPHENOTYPES REVEAL NOVEL VARIANTS POTENTIALLY INFORMATIVE FOR ALZHEIMER'S DISEASE (2016) (1)
ASSOCIATION OF FDG-PET BRAIN METABOLISM WITH ALZHEIMER’S DISEASE RISK GENES (2016) (1)
Altered connectome mapping in people with mild cognitive impairment and older adults with cognitive complaints (2013) (1)
ELEVATED CEREBRAL BLOOD FLOW IN PARTICIPANTS WITH SUBJECTIVE COGNITIVE DECLINE (2016) (1)
Volumetric, cortical thickness and grey matter density changes on MRI over 12 months: Relationship to conversion status in the ADNI cohort (2009) (1)
Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study. (2022) (1)
Testing influences of APOE and BDNF genes and heart failure on cognitive function. (2020) (1)
Integrative analysis of DNA methylation and gene expression identifies genes associated with biological aging in Alzheimer's disease (2022) (1)
Temporal stability of the ventral attention network and general cognition along the Alzheimer’s disease spectrum (2021) (1)
ASSOCIATIONS BETWEEN SOCIAL NETWORK CHARACTERISTICS AND CORTICAL THICKNESS AND HIPPOCAMPAL VOLUME IN COGNITIVELY NORMAL SUBJECTS (2017) (1)
Gray matter density correlates of judgment deficits in older adults with AD, MCI, and cognitive complaints: Validation of the Dartmouth Rabin Judgment Questionnaire (DRJQ) (2005) (1)
Diffusion Tensor MRI in Preclinical Alzheimer's Disease: Decreased Fractional Anisotropy in Parahippocampal White Matter in MCI and Older Adults with Cognitive Complaints (2010) (1)
GENETIC FINDINGS USING ADNI MULTIMODAL QUANTITATIVE PHENOTYPES: A 2016 UPDATE (2017) (1)
Visual Contrast Sensitivity Assessment in Early Stages of Alzheimer's Disease: A Preliminary Study Using Frequency Doubled Technology (2008) (1)
ASSOCIATION OF PLASMA LEPTIN/ADIPONECTIN RATIO IN MEN WITH CSF BIOMARKERS IN THE ADNI-1 COHORT (2014) (1)
Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer’s disease (2012) (1)
VOLUMETRIC COMPARISON OF AUTOMATICALLY SEGMENTED HIPPOCAMPAL SUBFIELDS FROM 4-MIN ACCELERATED VERSUS 8-MIN T2-WEIGHTED 3T MRI SCANS (2016) (1)
Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis (2021) (1)
Amyloid and tau PET in sporadic early‐onset Alzheimer’s disease: Preliminary results from LEADS (2020) (1)
Polygenic mediation analysis of Alzheimer's disease implicated intermediate amyloid imaging phenotypes (2020) (1)
Analysis of the Inverse Association between Cancer and Alzheimer’s Disease: Results from the Alzheimer’s Disease Neuroimaging Initiative Cohort (2014) (1)
Longitudinal Early‐onset Alzheimer’s Disease Study (LEADS) genetic screening: Initial results (2021) (1)
Amygdalar atrophy as the genetically mediated hub of limbic degeneration in Alzheimer's disease (2017) (1)
Visual contrast sensitivity in AD, MCI, & older adults with cognitive complaints Neurobiol Aging. Author manuscript; available in PMC (2013) (1)
SUBJECTIVE COGNITIVE DECLINE (SCD) AND MILD BEHAVIORAL IMPAIRMENT (MBI): THE INTERSECTION OF TWO EARLY INDICATORS OF AD PATHOPHYSIOLOGY (2018) (1)
Novel CYP1B1-RMDN2 Alzheimers disease locus identified by genome-wide association analysis of cerebral tau deposition on PET (2023) (1)
VISUAL CONTRAST SENSITIVITY IS ASSOCIATED WITH AMYLOID AND TAU DEPOSITION (2017) (1)
Injury and Disease Linkages Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative * (2014) (1)
Visual contrast sensitivity as a novel biomarker for neurodegeneration in early Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints (2010) (1)
fMRI of Memory in Aging and Dementia (2010) (1)
Brain-wide structural connectivity alterations under the control of Alzheimer risk genes (2020) (1)
Association analysis of candidate SNPs on hippocampal volume and shape in mild cognitive impairment and older adults with cognitive complaints (2010) (1)
Imaging Brain Networks After Cancer and Chemotherapy: Advances Toward Etiology and Unanswered Questions. (2016) (1)
AXONAL DENSITY IS ASSOCIATED WITH SUBJECTIVE COGNITIVE DECLINE (SCD) IN OLDER ADULTS ASSESSED USING THE COGNITIVE CHANGE INDEX (2017) (1)
IC-P2-152: Working memory activation in MCI and older adults with cognitive complaints (2008) (1)
Transcriptomics, metabolomics, lipidomics, metabolic flux and mGWAS analyses of sphingolipid pathway highlights novel drugs for Alzheimer’s disease (2021) (1)
Consistency of Graph Theoretical Measurements of Alzheimer’s Disease Fiber Density Connectomes Across Multiple Parcellation Scales (2022) (1)
Interactive Visualization of Deep Learning for 3D Brain Data Analysis (2021) (1)
Genome-wide association study of CSF biomarkers amyloid beta 1-42, tau and tau phosphorylated at threonine 181 in the ADNI cohort (2010) (1)
A ROBUST, SIMPLIFIED BRAAK-TYPE CLASSIFICATION SCHEME FOR FLORTAUCIPIR F-18 TAU PET IMAGES (2017) (1)
Single Nuclei Transcriptome Reveals Perturbed Brain Vascular Molecules in Alzheimer’s Disease (2021) (1)
Prevalence and growth of cerebral microhemorrhages in autosomal dominant Alzheimer's disease (2013) (1)
Visual Contrast Sensitivity as a Novel Biomarker for Neurodegeneration in Early Alzheimer's Disease, Mild Cognitive Impairment, and Older Adults with Cognitive Complaints (2010) (1)
Hippocampal transcriptome-guided gene-gene interaction of memory phenotype in MCI and Alzheimer’s disease (2013) (1)
A META-ANALYSIS IDENTIFIES ADORA2A ASSOCIATED WITH HIPPOCAMPAL VOLUME IN ALZHEIMER’S DISEASE (2016) (1)
Association of Brain Volume and Retinal Thickness in the Early Stages of Alzheimer's Disease. (2022) (1)
Transcriptomic profiles underlying functional brain networks at different stages of Alzheimer’s disease (2020) (1)
Comprehensive genetic analysis of the human lipidome identifies novel loci controlling lipid homeostasis with links to coronary artery disease (2021) (1)
Heritability of regional brain volumes in large-scale neuroimaging and genetic studies (2017) (1)
Preliminary analysis of copy number variation in the ADNI cohort (2010) (1)
Integrative analysis of eQTL and GWAS summary statistics reveals transcriptomic alteration in Alzheimer brains (2022) (1)
Relationship of microglial activation measured by [11C]PBR28 PET, atrophy on MRI and plasma biomarkers in individuals with and at-risk for Alzheimer's disease (2013) (1)
WHOLE BRAIN SURFACE-BASED ANALYSIS IDENTIFIED BRAIN ATROPHY ASSOCIATED WITH SNPS IN FRMD6 LINKED TO ALZHEIMER'S DISEASE (2016) (1)
Temporal stability of the ventral attention network and general cognition along the Alzheimer's disease spectrum (2020) (1)
Diffusion tensor mri in preclinical AD: Diffusivity and anisotropy in MCI and older adults with cognitive complaints (2005) (1)
Functional and morphometric MRI evidence of specific structure/function relationships underlying memory dysfunction in early Alzheimer's disease (2000) (1)
EXAMINING THE EFFECT OF THE TOP 20 AD RISK VARIANTS ON BRAIN AMYLOIDOSIS, STRUCTURAL ATROPHY AND METABOLISM (2016) (1)
Self-reported versus informant-based cognitive complaints: Relation of E-Cog scores to imaging biomarkers and clinical status in ADNI-2 (2013) (1)
Differential Brain Atrophy Patterns and Neurogenetic Profiles in Cognitively-Defined Alzheimer’s Disease Subgroups (2020) (1)
Integrative metabolomics‐genomics approach reveals that pathways related to the metabolism of acylcarnitines and amines are new potential targets of Alzheimer’s disease (2020) (1)
Tau deposition and structural connectivity demonstrate differential association patterns with neurocognitive tests (2021) (1)
WEVar: a novel statistical learning framework for predicting noncoding regulatory variants (2020) (1)
Two-dimensional enrichment analysis for mining high-level imaging genetic associations (2016) (1)
Hippocampal shape in schizophrenia: A deformation-based morphometric analysis (2001) (1)
Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study (2022) (1)
Identifying genetic markers enriched by brain imaging endophenotypes in Alzheimer’s disease (2022) (1)
Erratum to “A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's Disease in the ADNI cohort” [Neuroimage 60/3(2012) 1608–1621] (2012) (1)
THE COGNITIVE CHANGE INDEX AS A MEASURE OF SUBJECTIVE COGNITIVE DECLINE AND INFORMANT PERCEPTION: RELATION TO TEST PERFORMANCE (2014) (1)
Disrupted functional connectivity in autosomal dominant Alzheimer's disease: Preliminary findings from the DIAN study (2012) (1)
TWO-YEAR LONGITUDINAL CHANGE IN AMYLOID DEPOSITION, GLUCOSE METABOLISM, AND HIPPOCAMPAL ATROPHY IN ADNI-2 PARTICIPANTS: RELATION TO GENETIC RISK (2014) (1)
Effect of SNR of DTI on the structural network (2010) (1)
NOVEL MODELS OF LATE-ONSET ALZHEIMER’S DISEASE BASED ON GWAS (2018) (1)
A Non-Synonymous SHARPIN Variant is Associated with Limbic Degeneration and Family History of Alzheimer’s Disease (2019) (1)
Racial‐ethnic differences in baseline and longitudinal change in neuropsychological test scores in the NACC Uniform Data Set 3.0 (2021) (1)
A Network-Based Framework for Mining High-Level Imaging Genetic Associations (2018) (1)
KLK8 AS A MODULATOR OF ALZHEIMER’S DISEASE PATHOLOGY: NEUROIMAGING GENETICS (2017) (1)
LINKING MEASURES OF SUBJECTIVE COGNITION ACROSS INTERNATIONAL AGING STUDIES USING ITEM RESPONSE THEORY (2017) (1)
Hippocampal subfield atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Cohort: Relationships to diagnosis and memory impairment (2012) (1)
Factors influencing Blacks and Whites participation in Alzheimers disease biomarker research (2022) (1)
ASSOCIATION OF [18F]AV-1451 TAU MARKERS WITH COGNITIVE AND NEURODEGENERATION MEASURES: PRELIMINARY ANALYSIS IN THE ADNI COHORT (2016) (0)
835 Maintenance Medications for Cyclic Vomiting Syndrome Affect Gray Matter Density in Brain Areas Serving Autonomic Function (2015) (0)
Disrupted functional connectivity in autosomal dominant Alzheimer’s disease demonstrates network specificity and precedes brain volume loss: Findings from the Dominantly Inherited Alzheimer Network (2013) (0)
Gwas of longitudinal amyloid PET identifies IL1RAP as a new potential Alzheimer's disease target (2015) (0)
Changes in frontal lobe activation after mild traumatic brain injury (MTBI) are related to performance on a fMRI working memory task (2000) (0)
TWO-YEAR LONGITUDINAL CHANGE IN AMYLOID DEPOSITION, GLUCOSE METABOLISM, AND HIPPOCAMPAL ATROPHY IN ADNI-2 PARTICIPANTS: RELATION TO GENETIC RISK (2014) (0)
Serum metabolome informs neuroimaging biomarkers for Alzheimer’s disease (2020) (0)
VISUAL AND AUDITORY CHANGES ARE ASSOCIATED WITH NEUROIMAGING BIOMARKERS DURING PRODROMAL STAGES OF ALZHEIMER'S DISEASE (2014) (0)
SCENE ENCODING FMRI IN SUBJECTIVE COGNITIVE DECLINE (2016) (0)
COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY- VERSUS LATE-ONSET AMYLOID-NEGATIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS (2017) (0)
P 3 P 3001 MITOCHONDRIAL GENOME-WIDE ASSOCIATION STUDYOFALZHEIMER ’ S DISEASE (2013) (0)
GLOBAL CORTICAL [F18]FLORTAUCIPIR ASSOCIATION WITH THE TOP 20 ALZHEIMER’S DISEASE RISK GENES (2019) (0)
Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration (2020) (0)
ASSOCIATION BETWEEN PLASMA Aβ LEVELS AND CEREBRAL AMYLOID AND TAU DEPOSITION (2018) (0)
Genome-wide pathway analysis of memory impairment in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks (2012) (0)
VEGFA IS ASSOCIATED WITH CEREBRAL BLOOD FLOW AND WHITE MATTER HYPERINTENSITY IN MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (2017) (0)
Social enrichment on the job: Complex work with people improves episodic memory, promotes brain reserve, and reduces the risk of dementia. (2023) (0)
OPTIMIZING COGNITIVE CHANGE INDEX CUTOFFS BASED ON COGNITIVE DECLINE AND BIOMARKER POSITIVITY IN COGNITIVELY NORMAL OLDER ADULTS (2017) (0)
Identification of concordant plasma lipid signatures in Alzheimer’s disease: Validation between two independent studies of Alzheimer’s disease (2020) (0)
SU35GENOME-WIDE SEQUENCING AND DATA-DRIVEN NEUROANATOMICAL MRI ANALYSIS SUGGESTS SHARPIN MISSENSE VARIANT FOR ALZHEIMER'S DISEASE (2019) (0)
A voxel-based morphometry study of volumetric MRI in familial Alzheimer's disease (2012) (0)
SPATIALLY SELECTIVE TAU-RELATED WHITE-MATTER PATHWAY ALTERATIONS IDENTIFIED BY A DATA-DRIVEN APPROACH (2019) (0)
Leveraging longitudinal, multi‐site diffusion MRI data in conjunction with free‐water analysis to characterize patterns of white matter neurodegeneration in aging (2022) (0)
BLOOD GENE EXPRESSION CHANGES IMPLICATED IN ALZHEIMER’S DISEASE (2016) (0)
Glucose hypometabolism in gerstmann–sträussler–scheinker patients with the F198S mutation (2015) (0)
GENOME-WIDE, STAGE-SPECIFIC ASSOCIATION ACROSS ALZHEIMER’S DISEASE ENDOPHENOTYPES: MODELING SNP BY DIAGNOSIS INTERACTIONS (2019) (0)
MULTIVARIATE PATTERNS OF ASSOCIATION BETWEEN DIFFUSION IMAGING METRICS AND PLASMA NEUROFILAMENT LIGHT IN PRODROMAL ALZHEIMER’S DISEASE (2019) (0)
Integrative analysis of multi-omics and imaging data with incorporation of biological information via structural Bayesian factor analysis (2023) (0)
Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer’s disease (2016) (0)
Integrative analysis of eQTL and GWAS summary statistics reveals novel genes related to Alzheimer's disease (2021) (0)
POLYGENIC COMPOSITE SCORES IN ALZHEIMER’S DISEASE: A SYSTEMATIC REVIEW (2019) (0)
IMPROVING PREDICTION OF COGNITIVE OUTCOMES FROM FUNCTIONAL CONNECTIVITY IN ALZHEIMER’S DISEASE (2019) (0)
Genome‐wide analysis of longitudinal Alzheimer’s disease biomarker endophenotypes (2020) (0)
Longitudinal latent class mixture model analysis identifies subclasses of cognitive/neurodegeneration trajectory with differential patterns of genetic association (2021) (0)
THE RATIO OF CORTICAL AND HIPPOCAMPAL VOLUMES PREDICTS RATE OF CLINICAL DECLINE IN ALZHEIMER'S DISEASE (2016) (0)
ASSOCIATION OF [18F]AV-1451 TAU MARKERS WITH COGNITIVE AND NEURODEGENERATION MEASURES: PRELIMINARY ANALYSIS IN THE ADNI COHORT (2016) (0)
GENE EXPRESSION OF ABCA7 DYSREGULATED IN PERIPHERAL BLOOD IS ASSOCIATED WITH DECREASED METABOLIC ACTIVITY IN HIPPOCAMPUS (2016) (0)
Cognitive, neuropsychiatric and imaging comparisons between early‐onset and late‐onset Alzheimer’s disease participants from LEADS and ADNI3 (2021) (0)
Extension of a validation study of the cognitive change index (CCI) tool to measure self and informant perception of cognitive decline: Relation to test performance (2015) (0)
Multidimensional representations in late-life depression: convergence in neuroimaging, cognition, clinical symptomatology and genetics (2021) (0)
Relationship between CSF and plasma proteomic data in the ADNI-1 cohort (2012) (0)
ELEVATED PLASMA NEUROFILAMENT LIGHT CHAIN IS ASSOCIATED WITH REDUCED GREY MATTER DENSITY IN AD AND MCI (2017) (0)
Brain explorer for connectomic analysis (2017) (0)
ROLE OF SP1 AND OTHER TRANSCRIPTION FACTORS (TFS) IN ALZHEIMER’S DISEASE (AD) (2017) (0)
TOWARDS A PATHWAY MODELING APPROACH TO ALZHEIMER’S DISEASE DRUG DISCOVERY (2012) (0)
Sets of Co-regulated Serum Lipids are Associated with Alzheimer Disease Pathophysiology (2019) (0)
THE COGNITIVE CHANGE INDEX IS ASSOCIATED WITH TAU DEPOSITION ON [18F]FLORTAUCIPIR (2018) (0)
RELATIONSHIP BETWEEN [18F]AV-1451 BINDING AND ANTECEDENT AMYLOID DEPOSITION, GLUCOSE HYPOMETABOLISM AND ATROPHY MEASURES: PRELIMINARY ANALYSIS IN THE ADNI COHORT (2016) (0)
A review of published genetic studies using ADNI multimodality quantitative phenotypes: MRI, PET, fluid biomarkers, cognition and clinical status (2013) (0)
EARLY AND LATE-ONSET ALZHEIMER’S DISEASE AND SUSPECTED NON-ALZHEIMER PATHOPHYSIOLOGY WITHIN THE A/T/N FRAMEWORK (2019) (0)
GENOME-WIDE META-ANALYSIS OF TRANSCRIPTOME PROFILING IDENTIFIES NOVEL DYSREGULATED GENES IMPLICATED IN ALZHEIMER’S DISEASE (2016) (0)
FDG-PET REVEALS DISTINCT HYPOMETABOLIC TRAJECTORIES IN COGNITIVELY DEFINED SUBGROUPS OF ALZHEIMER’S DISEASE (2019) (0)
NEUROIMAGING ,C ANCER, AND COGNITION :S TATE OF THE KNOWLEDGE (2013) (0)
Phone-Based Memory Test Predicts In-Clinic Memory, MCI Diagnosis, and Alzheimer’s Neuroimaging & Plasma Biomarkers (2023) (0)
Characterizing neurodegeneration in the human connectome: a network science study of hereditary diffuse leukoencephalopathy with spheroids (2015) (0)
Brain activation patterns associated with listening to trauma-related words in patients with schizophrenia and healthy controls: A preliminary FMRI study (2003) (0)
Profiling the metabolome of patients with dementia in the UK Biobank (2021) (0)
THE EFFECTS OF THE TOP 20 ALZHEIMER’S DISEASE RISK GENES ON BRAIN ATROPHY (2016) (0)
COGNITIVELY DEFINED LOAD SUBGROUPS ARE CHARACTERIZED BY HETEROGENEOUS PATTERNS OF RELATIVE DEFICITS IN THE FIVE YEARS PRECEDING LOAD DIAGNOSIS (2018) (0)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology‐Specific (2023) (0)
ANTICHOLINERGIC MEDICATION USE IS ASSOCIATED WITH REDUCED FMRI ACTIVITY DURING VISUAL EPISODIC ENCODING IN COGNITIVELY NORMAL OLDER ADULTS (2017) (0)
Model-based analysis of continuous performance memory assessment demonstrates mechanisms underlying deficits in mild cognitive impairment (2015) (0)
Assessing the Clinical Meaningfulness of the Alzheimer’s Disease Composite Score (ADCOMS) Tool (2022) (0)
Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease (2022) (0)
Genetic heterogeneity of four MCI/AD neuroanatomical dimensions discovered via deep learning (2022) (0)
COVARYING PATTERNS OF FUNCTIONAL CONNECTIVITY WITH AMYLOID AND TAU DEPOSITION IN EARLY STAGE ALZHEIMER’S DISEASE (2019) (0)
Plasma tau is negatively correlated with frontal lobe CBF in hypertensive adults on the AD spectrum (2020) (0)
UNRAVELING THE AMBIGUITY BETWEEN COGNITION AND DEPRESSION: A LONGITUDINAL ANALYSIS OF OLDER ADULTS (2022) (0)
Functional biological paths altered in Alzheimer’s disease: from genes to bile acids (2020) (0)
The open diffusion data derivatives, brain data upcycling via integrated publishing of derivatives and reproducible open cloud services (2018) (0)
WHOLE GENE-BASED ASSOCIATION OF BASELINE PLASMA HOMOCYSTEINE IN THE ADNI-1 COHORT (2014) (0)
Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease (2020) (0)
PATHOLOGY IN THE EARLY ALZHEIMER’S PRODROME: SELF AND INFORMANT COGNITIVE CONCERNS SHOW DIFFERENT PATTERNS OF ASSOCIATION WITH TAU DEPOSITION ON [18F]FLORTAUCIPIR PET IN AMYLOID-POSITIVE OLDER ADULTS (2017) (0)
Deep multi-omic network fusion for marker discovery of Alzheimer’s Disease (2022) (0)
A blood-based signature of cerebrospinal fluid Aβ1–42 status (2019) (0)
Transcriptome-guided neurogenesis gene pathway variation is associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease (2015) (0)
Deep trans-omic network fusion reveals altered synaptic network in Alzheimer’s Disease (2023) (0)
Genome-wide association study of Alzheimer's-related brain MRI traits identifies several loci influencing degeneration of the hippocampus (2012) (0)
A blood-based signature of cerebrospinal fluid Aβ1–42 status (2019) (0)
A spatio-temporal multi-modal data management and analysis environment for tracking MS lesions (2003) (0)
Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease (2022) (0)
POSTERIOR CEREBRAL ATROPHY ASSOCIATED WITH THE PSEN1 I229F MUTATION (2014) (0)
Factors influencing the participation of Black and White Americans in Alzheimer's disease biomarker research (2022) (0)
AMYLOID AND TAU BURDEN IMPROVE RESIDUAL APPROACHES TO COGNITIVE RESERVE QUANTIFICATION IN AD (2019) (0)
Prospective assessment of white matter integrity in adult stem cell transplant recipients (2015) (0)
STRUCTURAL CONNECTIVITY MAPPING IN THE HUMAN HIPPOCAMPAL SUBFIELDS USING SUPER-RESOLUTION HYDI (2019) (0)
Audio‐visual speech perception is associated with cerebral tau deposition on [18F]flortaucipir PET (2020) (0)
Data‐driven characterization of tau accumulation across the Alzheimer’s disease spectrum (2020) (0)
PATHOLOGY IN THE EARLY ALZHEIMER’S PRODROME: SELF AND INFORMANT COGNITIVE CONCERNS SHOW DIFFERENT PATTERNS OF ASSOCIATION WITH TAU DEPOSITION ON [18F]FLORTAUCIPIR PET IN AMYLOID-POSITIVE OLDER ADULTS (2017) (0)
Hippocampal transcriptome-guided gene-gene interaction of memory phenotype in MCI and Alzheimer's disease (2013) (0)
TROI - A training and research system for tracing regions of interest in brain images (2001) (0)
Longitudinal structural MRI changes in Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints: relationship to conversion status (2011) (0)
Protective variant for rate of hippocampal volume loss identified by whole exome sequencing in APOE-ε3ε3 males with MCI (2013) (0)
IC-P-178 COMPARING HIPPOCAMPAL EFFECT SIZE BETWEEN ALZHEIMER’S DISEASE AND HEALTHY CONTROLS USING OLDER AND NEWER VERSIONS OF SPM AND FREESURFER OF IN VIVO STRUCTURAL AND MOLECULAR IMAGING MARKERS OF CHOLINERGIC SYSTEMDEGENERATION IN PD-RELATED COGNITIVE (2018) (0)
SCENE ENCODING FMRI IN SUBJECTIVE COGNITIVE DECLINE (2016) (0)
COGNITIVELY DEFINED SUBTYPES OF ALZHEIMER’S DISEASE ARE ASSOCIATED WITH DISTINCT PATTERNS OF ATROPHY (2018) (0)
HYBRID DIFFUSION IMAGING (HYDI) OF WHITE MATTER CHANGES IN OLDER ADULTS WITH SUBJECTIVE COGNITIVE DECLINE (SCD): ASSESSMENT OF ORIENTATION DISPERSION AND AXONAL DENSITY (2016) (0)
Differences in Motivators, Barriers, and Incentives between Black and White Older Adults for Participation in Alzheimers Disease Biomarker Research (2022) (0)
BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease (2021) (0)
Influence of PARP1 haplotype on [11C]PBR28 PET brain uptake (2013) (0)
O45. Blood Biomarkers for Possible Early Detection of Risk for Alzheimer Disease (AD) (2019) (0)
From systems biology to precision medicine: Leveraging heterogeneity (2020) (0)
ANTICHOLINERGIC MEDICATION USE IS ASSOCIATED WITH REDUCED FMRI ACTIVITY DURING VISUAL EPISODIC ENCODING IN COGNITIVELY NORMAL OLDER ADULTS (2017) (0)
COMBINATORIAL SENSORY MODALITY ASSESSMENT IN PRODROMAL ALZHEIMER’S DISEASE: RELATION TO MRI AND AMYLOID AND TAU PET (2018) (0)
Identification of exon skipping events associated with Alzheimer’s disease in the human hippocampus (2019) (0)
Visual contrast sensitivity in MCI and older adults with cognitive complaints is associated with altered resting connectivity in the visual network (2012) (0)
COMBINATORIAL SENSORY MODALITY ASSESSMENT IN PRODROMAL ALZHEIMER’S DISEASE: RELATION TO MRI AND AMYLOID AND TAU PET (2018) (0)
Reply: To PMID 25559091. (2015) (0)
COGNITIVE IMPAIRMENT IN OLDER ADULTS WITH MCI DUE TO SNAP MAY BE PARTIALLY ATTRIBUTABLE TO COMORBID CONDITIONS AND USE OF ANTICHOLINERGIC MEDICATION (2019) (0)
The trend of disruption in the functional brain network topology of Alzheimer’s disease (2021) (0)
STRUCTURAL CONNECTIVITY MAPPING IN THE HUMAN HIPPOCAMPAL SUBFIELDS USING SUPER-RESOLUTION HYDI (2019) (0)
Hippocampal subfield atrophy on 3T MRI in prodromal Alzheimer's disease and older adults with cognitive complaints (2012) (0)
Beyond the Uniform Data Set (UDS): Benefits of incorporating additional items for the measurement of memory, executive functioning, and language from the University of Pittsburgh Alzheimer’s Disease Research Center (2022) (0)
Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort (2011) (0)
PLASMA TAU LEVELS IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE (2016) (0)
CSF Aβ1-42 AS THE PATHOLOGICAL AD BIOMARKER IN TYPE 2 DIABETES MELLITUS PATIENTS (2017) (0)
ALZHEIMER’S DISEASE RISK GENES CAN PREDICT BRAIN AMYLOIDOSIS (2016) (0)
Personalized Prioritization of Cognitive Biomarkers in Alzheimer's Disease via Learning to Rank using Brain Morphometric Data (2020) (0)
COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY VERSUS LATE-ONSET AMYLOID-NEGATIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS (2017) (0)
Targeted lipidomic-pathway–guided genetic association with Alzheimer's disease–relevant endophenotypes (2013) (0)
Dysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI (2012) (0)
Hearing Impairment and Correlations with Neuropsychological Function in Alzheimer's Disease, Mild Cognitive Impairment and Older Adults with Cognitive Complaints (2007) (0)
Author Correction: The human connectome in Alzheimer disease — relationship to biomarkers and genetics (2021) (0)
OP-JNCI170361 223..231 (2018) (0)
A TOPOGRAPHIC IMAGING BIOMARKER OF TDP43 PATHOLOGY IN AMNESTIC DEMENTIA BASED ON AUTOPSY-DERIVED FDG-PET PATTERNS (2019) (0)
LONGITUDINAL RATES OF ATROPHY IN FAMILIAL ALZHEIMER'S DISEASE (2014) (0)
White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer’s disease continuum (2023) (0)
Anxiety in Late Life Depression: Associations with Brain Structure and Functional Impairment (2023) (0)
Association of eye disease with increased diffusivity in the sagittal stratum (2015) (0)
Expertise both in shape analysis and application to schizophrenia (2010) (0)
ASSOCIATION OF THE COGNITIVE CHANGE INDEX WITH HIPPOCAMPAL SUBFIELD VOLUMES (2016) (0)
Pairwise gene-protein association analysis on cerebrospinal fluid proteomics in the ADNI-1 cohort (2012) (0)
Genome-wide analysis of genetic variants associated with depressive symptoms in older adults (2013) (0)
IC-P-084 EFFECTS OFAGE AND CSFMEASURES OF TAUONMNEMONICDISCRIMINATIONOF OBJECTS AND SCENES IN MEDIAL TEMPORAL LOBE PATHWAYS (2018) (0)
Tu1790 Differences in Gray Matter Density Between Patients With Cyclic Vomiting Syndrome and Healthy Controls (2014) (0)
IDENTIFICATION OF DISCRIMINATIVE BRAIN IMAGING AND GENOMIC ASSOCIATIONS: AN ALZHEIMER’S DISEASE STUDY (2016) (0)
Increased Bridging Characteristics in Social Networks are Associated with Increasing Amygdala Volume and Grey Matter Density (2022) (0)
Longitudinal GWAS Identifies Novel Genetic Variants and Complex Traits Associated with Resilience to Alzheimer’s Disease (2022) (0)
RELATIONSHIP BETWEEN [18F]AV-1451 BINDING AND ANTECEDENT AMYLOID DEPOSITION, GLUCOSE HYPOMETABOLISM AND ATROPHY MEASURES: PRELIMINARY ANALYSIS IN THE ADNI COHORT (2016) (0)
Anticholinergic medication use in older adults is associated with memory and hippocampal volume (2015) (0)
Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment (2021) (0)
Leveraging longitudinal, multi‐site diffusion MRI data in conjunction with free‐water analysis to characterize patterns of white matter neurodegeneration in aging (2022) (0)
Network-based analysis of genetic variants associated with hippocampal volume in Alzheimer’s disease: a study of ADNI cohorts (2016) (0)
Genome Wide Analysis Across Alzheimer's Disease Endophenotypes: Main Effects and Stage Specific Interactions (2021) (0)
SPATIALLY SELECTIVE TAU-RELATED WHITE-MATTER PATHWAY ALTERATIONS IDENTIFIED BY A DATA-DRIVEN APPROACH (2019) (0)
Structural connectivity mapping in human hippocampal-subfields using super-resolution hybrid diffusion imaging: a feasibility study (2022) (0)
COGNITIVE COMPLAINTS IN POSTMENOPAUSAL WOMEN ARE ASSOCIATED WITH REDUCED HIPPOCAMPAL GRAY MATTER VOLUME (2018) (0)
UTILITY OF PERFUSION PET MODELS AS MEASURES OF NEURODEGENERATION IN AN AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE POPULATION: REPORT FROM THE DIAN STUDY (2017) (0)
APOE e4 status modulates the association of plasma and cortical Aβ: Relation of plasma Aβ and [11C]PiB PET in the ADNI cohort (2011) (0)
Response to “REST rs3796529 variant does not influence human subcortical brain structures” (2016) (0)
Increased white matter MRI T1 hypointensity volume in young‐onset Alzheimer’s disease patients is not accounted for by age or cardiovascular risk factors (2020) (0)
Integrative ‐omics for discovery of network‐level disease biomarkers for Alzheimer’s disease (2021) (0)
IC-P-066 COGNITIVE IMPAIRMENT IN IN OLDER ADULTSWITHMCI DUE TO SNAP MAY BE PARTIALLYATTRIBUTABLE TO COMORBID CONDITIONS AND USE OF ANTICHOLINERGIC MEDICATION (2019) (0)
INVESTIGATION OF GENETIC INFLUENCES ON ATROPHY RATE DURING THE MCI DISEASE STAGE USING A BOOTSTRAP-ENHANCED SPARSE ASSOCIATION MODEL (2017) (0)
THE ALZHEIMER’S METABOLOME: RELATIONSHIP TO PATHOLOGICAL MARKERS AND COGNITIVE DECLINE IN THE ALZHEIMER’S DISEASE NEUROIMAGING INITIATIVE (ADNI) (2016) (0)
LANGUAGE FLUENCY PREDICTS RESTING STATE NETWORK CONNECTIVITY PATTERN (2017) (0)
FDG-PET REVEALS DISTINCT HYPOMETABOLIC TRAJECTORIES IN COGNITIVELY-DEFINED SUBGROUPS OF ALZHEIMER’S DISEASE (2019) (0)
ASSOCIATION OF THE COGNITIVE CHANGE INDEX WITH HIPPOCAMPAL SUBFIELD VOLUMES (2016) (0)
GENOME-WIDE META-ANALYSIS OF TRANSCRIPTOME PROFILING IDENTIFIES NOVEL DYSREGULATED GENES IMPLICATED IN ALZHEIMER’S DISEASE (2016) (0)
P2-011 A BIOENERGETIC TRAJECTORY OF FEMALE BRAIN AGING AND ALZHEIMER’S DISEASE 1: IMPLICATIONS FOR RISK PREVENTION AND TREATMENT (2013) (0)
Identifying multimodal imaging‐driven subtypes in mild cognitive impairment using deep multiview learning (2021) (0)
GENE EXPRESSION OF ABCA7 DYSREGULATED IN PERIPHERAL BLOOD IS ASSOCIATED WITH DECREASED METABOLIC ACTIVITY IN HIPPOCAMPUS (2016) (0)
Genome-wide network-based pathway analysis of CSF biomarker t-tau in the ADNI cohort (2015) (0)
Influence of PARP1 haplotype on [11C]PBR28 PET brain uptake (2013) (0)
P2-181 Regionally specific atrophy of the corpus callosum in Alzheimer's disease and mild cognitive impairment (2004) (0)
A network‐based, multi‐omics atlas for target identification and prioritization in Alzheimer’s disease (2020) (0)
GUT DERIVED BILE ACID METABOLITES CORRELATE WITH STRUCTURAL AND FUNCTIONAL NEUROIMAGING MEASURES IN ALZHEIMER’S DISEASE (2017) (0)
Volumetric comparison of hippocampal subfields extracted from 4-minute accelerated vs. 8-minute high-resolution T2-weighted 3T MRI scans (2018) (0)
Functional magnetic resonance imaging during memory processing: Focal anterior hippocampal activation is reproducible across subjects and encoding tasks (1996) (0)
Machine learning for Alzheimer’s disease classification from genomic tiling variants (2022) (0)
Preliminary analysis of copy number variation in the ADNI cohort (2010) (0)
Within and Between Session Reproducibility of MR Perfusion using PICORE Q 2 TIPS at 3 T (2008) (0)
Amyloid and Tau Pathology are Associated with Cerebral Blood Flow in Nondemented Older Adults with and without Vascular Risk Factors for Alzheimer's Disease (2022) (0)
ASSOCIATED WITH GENETIC RISK FACTORS IN ALZHEIMER ’ S DISEASE (2015) (0)
VISUAL AND AUDITORY CHANGES ARE ASSOCIATED WITH NEUROIMAGING BIOMARKERS DURING PRODROMAL STAGES OF ALZHEIMER'S DISEASE (2014) (0)
Brain activation during episodic scene encoding is associated with amyloid and tau levels in amyloid‐positive older adults (2021) (0)
Variants in the Mitochondrial Intermediate Peptidase (MIPEP) Gene are Associated with Gray Matter Density in the Alzheimer’s Disease Neuroimaging Initiative Cohort (2015) (0)
Deep learning detection of informative features in [18F] flortaucipir PET for Alzheimer’s disease classification (2020) (0)
Cognition and brain structure in Gerstmann-Straussler-Scheinker disease (PRNP F198S) (2010) (0)
VKučinskas-2001-2016 (2016) (0)
Glucose hypometabolism in gerstmann–sträussler–scheinker patients with the F198S mutation (2015) (0)
Rare variants in the splicing regulatory elements of EXOC3L4 are associated with brain glucose metabolism in Alzheimer’s disease (2018) (0)
Sex and APOE‐ε4 carrier effects on early‐onset Alzheimer’s disease pathology (2022) (0)
RARE VARIANT IN PLD3 IS ASSOCIATED WITH ALZHEIMER'S PATTERN OF NEURODEGENERATIVE CHANGES (2014) (0)
ALZHEIMER’S DISEASE RISK GENES CAN PREDICT BRAIN AMYLOIDOSIS (2016) (0)
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study (2012) (0)
Effect of hypertension and antihypertensive medication on executive function, brain atrophy, and white matter hyperintensities (2015) (0)
Abstract B018: Long-term epigenetic aging in older breast cancer survivors and non-cancer controls: Preliminary findings from the Thinking and Living with Cancer (TLC) Stud (2023) (0)
Neuropsychologic I mpact o f S tandard-Dose S ystemic Chemotherapy i n L ong-Term S urvivors o f B reast C ancer and L ymphoma (2002) (0)
Neurodegeneration in the Longitudinal Evaluation of Early Onset Alzheimer’s Disease Study (LEADS) sample: Results from the MRI core (2020) (0)
PLASMA AMYLOID-BETA AND TAU AND VISUAL CONTRAST SENSITIVITY SYNERGISTICALLY PREDICT CEREBRAL AMYLOID AND TAU DEPOSITION ON PET IN PRECLINICAL AND PRODROMAL AD (2019) (0)
Resting-state fMRI activity profile in prodromal Alzheimer's disease and older adults with cognitive complaints (2011) (0)
PiB PET in Gerstmann-Sträussler-Scheinker disease (2016) (0)
BECA: A Software Tool for Integrated Visualization of Human Brain Data (2017) (0)
INCIDENCE OF DEMENTIA SUBTYPES IN A COMMUNITY-BASED PROSPECTIVE COHORT STUDY: THE ADULT CHANGES IN THOUGHT (ACT) STUDY (2016) (0)
REGIONAL DIFFERENCES IN CORTICAL THICKNESS ACROSS COGNITIVELY DEFINED ALZHEIMER’S DISEASE SUBGROUPS (2019) (0)
THE EFFECTS OF THE TOP 20 ALZHEIMER’S DISEASE RISK GENES ON BRAIN ATROPHY (2016) (0)
Cerebral hypometabolism in carriers of the intron 10 +3 MAPT mutation (2014) (0)
SEPARATION OF FUNCTIONAL CONNECTOMES ACROSS THE AD SPECTRUM BASED ON DISEASE SENSITIVE PRINCIPAL COMPONENTS (2018) (0)
Sex‐specific genetic predictors of memory, executive function, and language performance (2022) (0)
Understanding Neuropsychiatric Disorders: Functional imaging of Alzheimer's disease (2010) (0)
Effective Classification of 3 D Closed Surfaces : Application to Modeling Neuroanatomical Structures ∗ (2003) (0)
Plasma levels of interleukin-6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study. (2023) (0)
Dissociable Cellular and Genetic Mechanisms of Cortical Thinning at Different Life Stages (2022) (0)
Differences in neuropsychological performance between cognitively normal individuals with or without significant memory concerns using the cognitive change index (2015) (0)
BIN1 AND CR1 VARIANTS AFFECT COGNITIVE PERFORMANCE, NEURODEGENERATION, AND BRAIN AMYLOIDOSIS IN ADNI SUBJECTS (2014) (0)
ADVANCING CLINICAL AND BIOMARKER RESEARCH IN AD: THE LEAD STUDY (2019) (0)
SELECTIVE ESTROGEN EFFECTS ON CHOLINERGIC-RELATED COGNITIVE PERFORMANCE AND FMRI IN POSTMENOPAUSAL WOMEN WITH AND WITHOUT SUBJECTIVE COGNITIVE DECLINE (2017) (0)
Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [18F]Flortaucipir PET (2018) (0)
SEPARATION OF FUNCTIONAL CONNECTOMES ACROSS THE AD SPECTRUM BASED ON DISEASE-SENSITIVE PRINCIPAL COMPONENTS (2018) (0)
The differences in CD33 protein expression for AA and EA suggest that race and gender play a role in CD33 expression, the gene product of the CD33 susceptibility locus. P3-055 PREECLAMPSIA DURING PREGNANCYAND ALZHEIMER’S DISEASE LATER IN LIFE (2013) (0)
NEXT-GENERATION SEQUENCING OF THE BCHE LOCUS IDENTIFIES A FUNCTIONAL SNP ASSOCIATED WITH ALZHEIMER'S DISEASE BIOMARKERS AND AGE OF ONSET (2014) (0)
INCREASED AMYLOID DEPOSITION IN OLDER ADULTS AT RISK FOR PROGRESSION TO ALZHEIMER'S DISEASE DUE TO GENETIC BACKGROUND AND/OR THE PRESENCE OF SIGNIFICANT MEMORY CONCERNS (2014) (0)
ASSOCIATION ANALYSIS OF RARE VARIANTS NEAR THE APOE REGION WITH CEREBROSPINAL FLUID (CSF) BIOMARKERS OF ALZHEIMER'S DISEASE (2014) (0)
Dissecting pathogenic ApoE pathways with the ADNI dataset: The case for reelin (2011) (0)
DYSREGULATED FC GAMMA R-MEDIATED PHAGOCYTOSIS PATHWAY IN ALZHEIMER'S DISEASE: NETWORK-BASED GENE EXPRESSION ANALYSIS (2019) (0)
GPU Accelerated Browser for Neuroimaging Genomics (2018) (0)
Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates (2013) (0)
Audio‐visual speech perception is associated with cerebral tau deposition on [ 18 F]flortaucipir PET: Biomarkers (non‐neuroimaging) / novel biomarkers (2020) (0)
EP300 IS ASSOCIATED WITH ALTERED BILE ACIDS IN ALZHEIMER’S DISEASE (2018) (0)
Review Articles The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans (2010) (0)
Sex differences in APOE effects on cognition are domain‐specific (2022) (0)
Gwas identifies gli3 as a novel gene for language deficits and cortical changes in older adults at-risk for Alzheimer’s disease (2015) (0)
GENETIC VARIATION OF ANTI-AGING GENE FGF23 IS ASSOCIATED WITH LARGER CORTICAL THICKNESS IN ALZHEIMER’S DISEASE (2018) (0)
SUBSYNDROMAL DEPRESSIVE SYMPTOMS IN NON-DEMENTED OLDER ADULTS ARE ASSOCIATED WITH POORER MEMORY PERFORMANCE (2019) (0)
Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction (2023) (0)
3 D MRSI of Brain Neurochemical Changes in Breast Cancer Patients treated with Chemotherapy (2011) (0)
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2020) (0)
ASSOCIATION BETWEEN N-BACK WORKING MEMORY ACTIVATION ON FMRI AND COGNITIVE ASSESSMENT OF EXECUTIVE FUNCTION (2016) (0)
HYBRID DIFFUSION IMAGING (HYDI) OF WHITE MATTER CHANGES IN OLDER ADULTS WITH SUBJECTIVE COGNITIVE DECLINE (SCD): ASSESSMENT OF ORIENTATION DISPERSION AND AXONAL DENSITY (2016) (0)
Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations (2013) (0)
COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY- VERSUS LATE-ONSET AMYLOID-POSITIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS (2017) (0)
ImpactoftheAlzheimer'sDiseaseNeuroimagingInitiative,2004to2014 (2015) (0)
GENETIC FINDINGS USING ADNI MULTIMODAL QUANTITATIVE PHENOTYPES: A 2018 UPDATE (2018) (0)
Sex differences in white matter microstructure in aging and Alzheimer’s disease: A multi‐site free‐water imaging study (2022) (0)
Elevated plasma cortisol associated with larger ventricles and smaller hippocampal volumes – a study in 2 independent elderly cohorts (2020) (0)
GENOME-WIDE ANALYSES OF ISOLATED RELATIVE COGNITIVE IMPAIRMENTS IDENTIFIES SUGGESTIVE HITS IN FIVE STUDIES (2018) (0)
Cognitive symptoms in early postmenopausal women: Relationship to brain structure (2020) (0)
Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
Memory and Aging Telephone Screen (2013) (0)
Endophenotype driven polygenic risk scores for Alzheimer’s disease (2020) (0)
THE COGNITIVE CHANGE INDEX IS ASSOCIATED WITH TAU DEPOSITION ON [18F]FLORTAUCIPIR (2018) (0)
Biomarker‐based polygenic risk scores for profiling genetic susceptibility in Alzheimer's disease (2021) (0)
Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control Individuals. (2023) (0)
Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer’s disease (2021) (0)
Gene-based analyses of microglial activation on [11C]PBR28 PET in older adults at risk for Alzheimer's disease (2013) (0)
A Multimedia System for the Anatomical Study of Brain Images (0)
NEURODEGENERATIVE PATTERNS OF COGNITIVE CLUSTERS OF EARLY ONSET AD SUBJECTS: EVIDENCE FOR DISEASE HETEROGENEITY (2017) (0)
Association of cerebral microhemorrhages with amyloid deposition and hyperlipidemia (2015) (0)
COMPARING HIPPOCAMPAL EFFECT SIZE BETWEEN ALZHEIMER’S DISEASE AND HEALTHY CONTROLS USING OLDER AND NEWER VERSIONS OF SPM AND FREESURFER (2018) (0)
EFFECTS OF NEWLY IDENTIFIED TOP AD CANDIDATE GENES ON MEMORY PERFORMANCE: SNP, GENE, AND EPISTASIS ANALYSES IN ADNI (2014) (0)
Replication and meta-analysis of the CHRFAM7A copy number variant in a cohort of clinically characterized and neuropathologically verified individuals (2012) (0)
INTEGRATING MULTI-MODALITY IMAGING AND MULTI-LAYER -OMICS TO ADVANCE THE SYSTEMS BIOLOGY OF ALZHEIMER’S DISEASE (2017) (0)
Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer’s disease (2017) (0)
Preference Matrix Guided Sparse Canonical Correlation Analysis for Genetic Study of Quantitative Traits in Alzheimer’s Disease (2022) (0)
Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
Sparse Bayesian learning for identifying the neuroanatomical basis of cognitive impairment in Alzheimer’s disease (2013) (0)
Characterization of regional cerebral blood flow in people with mild cognitive impairment and older adults with cognitive complaints (2013) (0)
HIGH RED MEAT INTAKE IS ASSOCIATED WITH INCREASED TAU ON [18F]FLORTAUCIPIR PET AND POORER MEMORY (2018) (0)
DIFFERENTIAL CO-EXPRESSION ANALYSIS REVEALS EARLY STAGE GENE DIS-COORDINATION IN ALZHEIMER'S DISEASE (2019) (0)
Association of Retinal Nerve Fiber Layer Thickness with Plasma pTau181 and Aβ42/Aβ40 ratio (2022) (0)
ASSOCIATEDWITH HIPPOCAMPALVOLUME IN ALZHEIMER’S DISEASE (2019) (0)
Reply (2016) (0)
Reply (2015) (0)
Integrating whole-exome sequencing and imaging genetics to identify single-nucleotide variants associated with rate of hippocampal neurodegeneration in APOE-ε3/ε3 males with mild cognitive impairment (2012) (0)
Predictors of memory performance in a large, stratified, random population sample of older Americans: Clinical, demographic, lifestyle and genetic factors (2013) (0)
The role of APOE genotype in early mild cognitive impairment (E-MCI): Preliminary results from ADNI-2 (2012) (0)
Biological Hallmarks of Cancer in Alzheimer’s Disease (2019) (0)
Sex differences in the genetic architecture underlying resilience in AD (2021) (0)
Progressive white matter abnormalities in autosomal-dominant Alzheimer's disease: Results of the DIAN study (2012) (0)
[18F]-AV-1451 BINDING PROFILE IN EARLY AND LATE-ONSET ALZHEIMER’S DISEASE AND SUSPECTED NON-ALZHEIMER PATHOPHYSIOLOGY (2018) (0)
HIGH RED MEAT INTAKE IS ASSOCIATED WITH INCREASED TAU ON [18F]FLORTAUCIPIR PET AND POORER MEMORY (2018) (0)
Functional MRI of mild traumatic brain injury (mTBI): progress and perspectives from the first decade of studies (2012) (0)
DNA METHYLATION DYNAMICS IN ALZHEIMER’S DISEASE: DEVELOPMENT OF BIOMARKERS AND NOVEL DRUG TARGETS USING ADNI EPIGENETIC DATA (2018) (0)
Title Large-scale genomics unveil polygenic architecture of human cortical surface area Permalink (2015) (0)
COGNITIVE IMPAIRMENT IN IN OLDER ADULTS WITH MCI DUE TO SNAP MAY BE PARTIALLY ATTRIBUTABLE TO COMORBID CONDITIONS AND USE OF ANTICHOLINERGIC MEDICATION (2019) (0)
Network-based genome wide study of hippocampal imaging phenotype in Alzheimer's Disease to identify functional interaction modules (2017) (0)
Cognitive assessments in ADNI: Lessons learned from the ADNI psychometrics project (2021) (0)
Bootstrapped Sparse Canonical Correlation Analysis (2018) (0)
Apolipoprotein E ɛ4–related effects on cognition are limited to the Alzheimer’s disease spectrum (2021) (0)
Serum metabolites associate with biofluid neurofilament light chain in Alzheimer’s disease (2022) (0)
DEVELOPMENT OF A TAU BIOLOGICAL NETWORK FOR GENETIC ANALYSIS OF TAUOPATHIES (2017) (0)
Genome-wide association of plasma homocysteine in the indianapolis-ibadan dementia study cohort (2015) (0)
Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty (2017) (0)
COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY VERSUS LATE-ONSET AMYLOID-POSITIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS (2017) (0)
GENETIC FINDINGS USING ADNI MULTIMODAL QUANTITATIVE PHENOTYPES: A REVIEW OF PAPERS PUBLISHED IN 2013 (2014) (0)
Distinctive Patterns of Tau Accumulation and White-Matter Degeneration on Domain-Specific Neuropsychiatric Test Scores (2020) (0)
Pathway-based gene analysis identifies vegfa as a gene associated with cerebral blood flow in Alzheimer's disease (2015) (0)
ASSOCIATION BETWEEN N-BACK WORKING MEMORY ACTIVATION ON FMRI AND COGNITIVE ASSESSMENT OF EXECUTIVE FUNCTION (2016) (0)
Common gene networks underlying memory impairment: A comparison of pathway analysis methods in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort (2012) (0)
Response to Dekker, Stege, and Versteeg. (2021) (0)
Normative Modeling of Brain Morphometry Across the Lifespan Using CentileBrain: Algorithm Benchmarking and Model Optimization (2023) (0)
ADORA2A POLYMORPHISM IS ASSOCIATED WITH CEREBRAL BLOOD FLOW IN MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (2017) (0)
Identification of novel cortical surface biomarkers for predicting cognitive outcomes based on group-level` 2,1 norm (2012) (0)
Association of cerebral microhemorrhages with amyloid deposition and hyperlipidemia (2015) (0)
Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease (2018) (0)
Combining two large clinical cohorts (AIBL and ADNI) to identify multiple lipid metabolic pathways in prevalent and incident Alzheimer's disease. (2020) (0)
Cell‐Level Transcriptomic Network Analysis Provides Insights into Distinct Biological Mechanisms for Alzheimer’s Disease Enabling Targeted Drug Repositioning (2022) (0)
Explorer Epigenome-wide meta-analyses of blood DNA methylation and its association with subcortical volumes (2019) (0)
WHITE-MATTER MICROSTRUCTURE IN EARLY STAGE ALZHEIMER’S DISEASE (2018) (0)
GLOBAL CORTICAL [F18]FLORTAUCIPIR ASSOCIATION WITH THE TOP 20 ALZHEIMER’S DISEASE RISK GENES (2019) (0)
Anticholinergic medication use in older adults is associated with memory and hippocampal volume (2015) (0)
Age-related fMRI activation differences during semantic decision making in young and elderly adults (1999) (0)
WHITE-MATTER MICROSTRUCTURE IN EARLY STAGE ALZHEIMER’S DISEASE (2018) (0)
NEUROLOGICAL CORRELATES OF SOCIAL BONDING AND BRIDGING (2022) (0)
Development of harmonized and co‐calibrated scores for memory, executive functioning, language, and visuospatial in the AIBL Study, ADNI, and NACC datasets (2022) (0)
Influence of genetic variation on plasma proteomics in AD, MCI and controls: Pairwise gene-protein analysis in the ADNI-1 cohort (2011) (0)
POSTERIOR CEREBRAL ATROPHY ASSOCIATED WITH THE PSEN1 I229F MUTATION (2014) (0)
P3‐013: Withdrawn (2015) (0)
Neural correlates of semantic processing in older adults with cognitive complaints and amnestic MCI (2009) (0)
[18F]-AV-1451 BINDING PROFILE IN EARLY AND LATE-ONSET ALZHEIMER’S DISEASE AND SUSPECTED NON-ALZHEIMER PATHOPHYSIOLOGY (2018) (0)
Influence of history of traumatic brain injury on age at onset of cognitive impairment in MCI and Alzheimer's disease (2015) (0)
Brain Rehabilitation, Advanced Imaging, and Neuroscience (BRAIN): An IUPUI Signature Center Initiative (SCI) (2014) (0)
Disrupted functional connectivity in autosomal dominant Alzheimer’s disease demonstrates network specificity and precedes brain volume loss: Findings from DIAN (2013) (0)
LONGITUDINAL PATTERNS OF DECLINE IN SUBTYPES OF AMNESTIC EARLY ONSET AD (2018) (0)
Measuring Subjective Cognitive Decline in Older Adults: Harmonization between the Cognitive Change Index and the Measurement of Everyday Cognition Instruments (2019) (0)
Reply: To PMID 25559091. (2015) (0)
A SIMPLE METHOD FOR DEFINING ATROPHY SUBTYPES IN INDIVIDUAL SUBJECTS ACROSS THE ALZHEIMER DISEASE SPECTRUM (2018) (0)
CEREBROSPINAL FLUID ENDOPHENOTYPES PROVIDE INSIGHT INTO BIOLOGY UNDERLYING ALZHEIMER'S DISEASE (2017) (0)
WORKING MEMORY TASK-BASED FMRI IN SUBJECTIVE COGNITIVE DECLINE: EVIDENCE FOR NEURAL COMPENSATION (2019) (0)
Detection of MR perfusion transit time effects in pulsed arterial spin labeling using a ‘ model validity metric ’ (2010) (0)
Intact motor imagery in hemiplegia: Imagining the impossible (1999) (0)
Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (0)
LOSS OF Y CHROMOSOME: GENETICS AND ASSOCIATION WITH ALZHEIMER’S DISEASE ENDOPHENOTYPES (2019) (0)
REGIONAL ASSOCIATION OF CEREBRAL BLOOD FLOW WITH AMYLOID AND TAU IN ALZHEIMER’S DISEASE (2019) (0)
Visual contrast sensitivity as a novel biomarker: Discriminative analysis using elastic net to classify Alzheimer's disease, MCI and older adults with cognitive complaints (2012) (0)
EFFECTS OF NEWLY IDENTIFIED TOP AD CANDIDATE GENES ON MEMORY PERFORMANCE: SNP, GENE, AND EPISTASIS ANALYSES IN ADNI (2014) (0)
Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (0)
COMPARISON BETWEEN THREE VOLUMETRIC MRI Z-SCORE NORMING METHODS ACROSS THE ALZHEIMER DISEASE SPECTRUM (2018) (0)
An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. (2022) (0)
Mining High-Level Imaging Genetic Associations via Clustering AD Candidate Variants with Similar Brain Association Patterns (2022) (0)
The role of APOE-ɛ4 genotype in early mild cognitive impairment (EMCI): Preliminary results from ADNI-2 (2012) (0)
Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study (2018) (0)
PLASMA AMYLOID-BETA AND TAU AND VISUAL CONTRAST SENSITIVITY SYNERGISTICALLY PREDICT CEREBRAL AMYLOID AND TAU DEPOSITION ON PET IN PRECLINICAL AND PRODROMAL AD (2019) (0)
Effect of chemotherapy on default mode network connectivity in older women with breast cancer (2021) (0)
A ROBUST, SIMPLIFIED BRAAK-TYPE CLASSIFICATION SCHEME FOR FLORTAUCIPIR F 18 TAU PET IMAGES (2017) (0)
Potential Conflict of Interest (2023) (0)
Sex differences in genetic predictors of resilience to Alzheimer’s disease (2020) (0)
Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts (2019) (0)
Replication and meta-analysis of the CHRFAM7A copy number variant in a cohort of clinically characterized and neuropathologically verified individuals (2012) (0)
Protein‐protein interaction networks of genes associated with different cognitively defined subtypes of late‐onset Alzheimer's disease in five white populations identify novel candidate genes (2020) (0)
GENOME-WIDE PROTEIN INTERACTION GUIDED EPISTATIC ANALYSIS ON MEMORY PERFORMANCE: AN ADNI STUDY (2014) (0)
COVARYING PATTERNS OF FUNCTIONAL CONNECTIVITY WITH AMYLOID AND TAU DEPOSITION IN EARLY STAGE ALZHEIMER’S DISEASE (2019) (0)
Gray matter reduction in cognitively intact adults with the APOE E4 allele (2005) (0)
UTILITY OF PERFUSION PET MODELS AS MEASURE OF NEURODEGENERATION IN AN AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE POPULATION: REPORT FROM THE DIAN STUDY (2017) (0)
P4‐001: Withdrawn (2015) (0)
P2-095: Working memory activation in mild cognitive impairment and older adults with cognitive complaints (2008) (0)
Interplay of the human exposome, metabolome and gut microbiome in dementia and major depression (2022) (0)
HOW AGE AT INJURY AFFECTS THE LONG-TERM OUTCOMES OF TRAUMATIC BRAIN INJURY (2016) (0)
The role of visualization and 3-D printing in biological data mining (2015) (0)
Review Article Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders (2013) (0)
Single Cell Approaches Reveal Perturbed Brain Vascular Molecules in Alzheimer’s Disease (2022) (0)
Resting-state fMRI activity profile in prodromal Alzheimer's disease and older adults with cognitive complaints (2011) (0)
INFLUENCE OF PARKINSON’S DISEASE CANDIDATE GENES ON LEWY BODY PATHOLOGY IN AUTOPSY-CONFIRMED ALZHEIMER'S DISEASE CASES (2016) (0)
PLASMA A b AND CEREBRAL AND DEPOSITION THE GUT MICROBIOTA-DERIVED METABOLITE TRIMETHYLAMINE N-OXIDE (TMAO) IS ELEVATED IN ALZHEIMER’S (0)
DIACYLGLYCEROL PATHWAY-RELATED GENE PNPLA2 IS ASSOCIATED WITH CSF BIOMARKERS IN ALZHEIMER’S DISEASE (2018) (0)
Stability of MRI metrics in the advanced research core of the NCAA-DoD concussion assessment, research and education (CARE) consortium (2017) (0)
AXONAL DENSITY IS ASSOCIATED WITH SUBJECTIVE COGNITIVE DECLINE (SCD) IN OLDER ADULTS ASSESSED USING THE COGNITIVE CHANGE INDEX (2017) (0)
Imaging genetics of SPON1 gene variant rs11023139 in Alzheimer's disease (2013) (0)
Temporal stability of the ventral attention network and cognitive function along the Alzheimer’s disease spectrum (2020) (0)
THE RATIO OF CORTICAL AND HIPPOCAMPAL VOLUMES PREDICTS RATE OF CLINICAL DECLINE IN ALZHEIMER'S DISEASE (2016) (0)
S2. A Robust Measure of Pathological Neuroinflammation in the Human Cortex (2018) (0)
Accelerated Progression of Cognitive Impairment to Mild Cognitive Impairment and Dementia among People with Heart Failure (2019) (0)
PREDICTING COGNITIVE DECLINE AND BRAIN AMYLOIDOSIS USING COGNITIVE AND PERIPHERAL BLOOD GENE EXPRESSION MEASURES (2016) (0)
Brain connectivity changes and cognitive impairment after cancer treatment (2016) (0)
Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer’s disease (2018) (0)
[P4–059]: WITHDRAWN (2017) (0)
ASSOCIATION BETWEEN ESR1 AND COGNITION IN ADNI COHORT (2019) (0)
HEART FAILURE PREDICTS COGNITIVE DYSFUNCTION AFTER ADJUSTING FOR APOE FACTORS (2018) (0)
SERUM TRIGLYCERIDES IN ALZHEIMER'S DISEASE: RELATION TO NEUROIMAGING, CSF, AND GENETIC VARIATION (2019) (0)
MULTIVARIATE GENOME-WIDE ASSOCIATION STUDY OF CSF BIOMARKERS FOR ALZHEIMER’S DISEASE IDENTIFIES VARIANTS IN HLA CLASS I REGION PROVIDING FURTHER EVIDENCE FOR THE ROLE OF IMMUNE FUNCTION (2018) (0)
METABOLOMICS-GENOMICS INTEGRATIVE APPROACH REVEALED NEW CANDIDATE GENES RELATED TO ALZHEIMER’S DISEASE (2019) (0)
Quantifying Evolving Processes in Multimodal 3D Medical Images (2003) (0)
Association of retinal nerve fiber layer thickness with temporal lobe atrophy (2021) (0)
A review of published genetic studies using ADNI multimodality quantitative phenotypes: MRI, PET, fluid biomarkers, cognition and clinical status (2013) (0)
Abstract TP344: Extrahematomal CNS Barrier Disruption in the First 90 Days Following Primary Intracerebral Hemorrhage (2018) (0)
The nav2 (neuron navigator 2) gene as a common genetic influence across correlated episodic memory performances (2015) (0)
REVEALS DISTINCT HYPOMETABOLIC TRAJECTORIES IN COGNITIVELY-DEFINED SUBGROUPS OF ALZHEIMER’S DISEASE (2019) (0)
FUNCTIONAL CONNECTIVITY PATTERNS ACROSS COGNITIVELY-DEFINED ALZHEIMER’S DISEASE SUBTYPES IN THE ALZHEIMER’S DISEASE NEUROIMAGING INITIATIVE (2019) (0)
Elevated PiB precedes dementia in autosomal-dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort (2012) (0)
PREDICTING COGNITIVE DECLINE AND BRAIN AMYLOIDOSIS USING COGNITIVE AND PERIPHERAL BLOOD GENE EXPRESSION MEASURES (2016) (0)
Frontolimbic brain regions associated with agitation and aggression symptoms in MCI and AD over a 2-year period (2011) (0)
DYSREGULATED FC GAMMA R-MEDIATED PHAGOCYTOSIS PATHWAY IN ALZHEIMER'S DISEASE: NETWORK-BASED GENE EXPRESSION ANALYSIS (2019) (0)
Gene expression profiling identifies altered networks in late-onset Alzheimer’s disease: Immune response and mitochondrial process (2015) (0)
ALZHEIMER’S DISEASE TAU PET SUBTYPES IN THE ADNI SAMPLE (2018) (0)
COMPARATIVE ANALYSIS OF PIB IN VIVO WITH 6-CN-PIB AND Aβ-IMMUNOHISTOCHEMISTRY POSTMORTEM IN FAMILIAL ALZHEIMER DISEASE ASSOCIATED WITH THE PSEN1 I229F MUTATION (2014) (0)
GWAS OF HIPPOCAMPAL SUBFIELD AND NEIGHBORING CORTICAL STRUCTURE VOLUMES IDENTIFIES AN ERC1 LOCUS USING ADNI HIGH-RESOLUTION MRI DATA (2019) (0)
Influence of rare RELN variants on quantitative PET imaging and CSF phenotypes in late-onset Alzheimer’s disease (2015) (0)
White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimerâ•Žs disease (2019) (0)
COMPARING HIPPOCAMPAL EFFECT SIZE BETWEEN ALZHEIMER’S DISEASE AND HEALTHY CONTROLS USING OLDER AND NEWER VERSIONS OF SPM AND FREESURFER (2018) (0)
BLOOD BIOMARKERS FOR MEMORY: TOWARDS EARLY DETECTION OF RISK FOR ALZHEIMER DISEASE, PHARMACOGENOMICS, AND REPURPOSED DRUGS (2019) (0)
Disruption of gene co-expression network along the progression of Alzheimer's disease (2019) (0)
Pairwise gene-protein association analysis on CSF proteomics in the ADNI-1 cohort (2012) (0)
Lipidomic signatures for APOE genotypes provides new insights about mechanisms of resilience in Alzheimer’s disease (2021) (0)
Tensor encoding and decomposition of brain connectomes with application to tractography evaluation (2017) (0)
Influence of rural vs urban county composition on AD neuroimaging biomarkers (2020) (0)
FDG metabolism in the DIAN study of autosomal dominant Alzheimer's disease (2012) (0)
RARE VARIANT IN PLD3 IS ASSOCIATED WITH ALZHEIMER'S PATTERN OF NEURODEGENERATIVE CHANGES (2014) (0)
GENETIC FINDINGS USING ADNI MULTIMODAL QUANTITATIVE PHENOTYPES: A 2017 UPDATE (2018) (0)
LANGUAGE FLUENCY PREDICTS RESTING STATE NETWORK CONNECTIVITY PATTERN (2017) (0)
P1-405 REGIONAL ASSOCIATION OF CEREBRAL BLOOD FLOW WITH AMYLOID AND TAU IN ALZHEIMER’S DISEASE PRE-SCREENING MACHINE LEARNING MODEL FOR b -AMYLOID POSITIVE ENRICHMENT (2019) (0)
Subjective vs. Objective Memory Predictors of AD Biomarkers and Future Cognitive, Clinical, and Functional Decline (2022) (0)
Event-Related fMRI During Recently Learned versus Novel Words Shows Hippocampal and Differentially Lateralized Insular Signal Change (1998) (0)
LONGITUDINAL PATTERNS OF DECLINE IN SUBTYPES OF AMNESTIC EARLY ONSET AD (2018) (0)
Glycerophospholipids as Potential Serum Biomarkers for Traumatic Brain Injuries (2020) (0)
Fused multi-modal similarity network as prior in guiding brain imaging genetic association (2023) (0)
P2-194 Compensatory brain activity associated with novelty detection and habituation in MCI and cognitive complaints (2004) (0)
ASSOCIATION OF FDG-PET BRAIN METABOLISM WITH ALZHEIMER’S DISEASE RISK GENES (2016) (0)
Acute naming deficits following dominant temporal lobectomy: Effects of age of onset (1990) (0)
MRI results from the DIAN study The pattern of atrophy in familial Alzheimer disease : Volumetric (0)
Indiana Center for Brain Rehabilitation, Advanced Imaging, and Neuroscience (ICBRAIN): An IUPUI Signature Center Initiative (2012) (0)
Relationships of time‐varying resting state network stability and cognitive function along the Alzheimer’s disease spectrum (2020) (0)
VISUAL CONTRAST SENSITIVITY IS ASSOCIATED WITH AMYLOID AND TAU DEPOSITION (2017) (0)
SCENE-ENCODING ACTIVATION AND RESTING-STATE FUNCTIONAL CONNECTIVITY IN OLDER ADULTS WITH SUBJECTIVE COGNITIVE DECLINE AND MILD COGNITIVE IMPAIRMENT (2018) (0)
VISUAL LEARNING ON THE COGSTATE BATTERY IS ASSOCIATED WITH AMYLOID, TAU, AND NEURODEGENERATION IN COGNITIVELY NORMAL OLDER ADULTS (2017) (0)
GENOME-WIDE ASSOCIATION OF TOP ALZHEIMER’S DISEASE ENDOPHENOTYPES IN ADNI DATASET (2018) (0)
INFLUENCE OF RARE PSEN1 VARIANTS ON QUANTITATIVE STRUCTURAL IMAGING AND CSF PHENOTYPES IN LATE ONSET ALZHEIMER'S DISEASE (2014) (0)
Cognitive Performance and Self-Reported Functioning in Daily Life Among Those with Parkinson's Disease: A Brief Report (2020) (0)
ALTERED FMRI ACTIVATION PATTERN DURING VISUAL SCENE ENCODING IN AFFECTED AND NON-AFFECTED CARRIERS OF PSEN1 AND APP MUTATIONS (2014) (0)
Genetic Data Identify Dual‐enrolled Participants in Alzheimer's Disease and Related Dementia (ADRD) Studies (2022) (0)
Two-year outcome in older adults with cognitive complaints: Relation to baseline cognition, self- and informant ratings, genetics and imaging (2013) (0)
Cognitive decline and conversion to MCI and dementia in heart failure: A 12‐year follow‐up study (2020) (0)
Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N 0 1345 young and elderly subjects (2012) (0)
GENOME-WIDE ASSOCIATION ANALYSIS OF TAU ACCUMULATION IDENTIFIES ENRICHMENT OF NEUROGENESIS-RELATED PATHWAYS (2017) (0)
PSYCHOMETRICALLY-DEFINED LATE-ONSET ALZHEIMER’S DISEASE (LOAD) SUBGROUPS IN 5 STUDIES (TOTAL N = 4,170): PREVALENCE AT FIRST VISIT, ASSOCIATIONS WITH APOE GENOTYPE AND IGAP SNPS, AND GWAS (2017) (0)
Association of the top 20 Alzheimer's disease risk genes with [18F]flortaucipir PET (2022) (0)
Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers (2013) (0)
Multigraph Cluster Analysis of AD Candidate Genes via Human Brain Mapping (2022) (0)
Synchronized sigmoidal mixed‐effects model for dynamics of cognitive decline relative to onset of Alzheimer’s disease in aging adults in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) study. (2022) (0)
Identifying imaging genetics biomarkers in Alzheimer’s disease via integrating graph convolutional neural network and canonical correlation analysis (2021) (0)
GENETIC FINDINGS USING ADNI MULTIMODAL QUANTITATIVE PHENOTYPES: A REVIEW OF PAPERS PUBLISHED IN 2013 (2014) (0)
EARLY- AND LATE-ONSET ALZHEIMER’S DISEASE AND SUSPECTED NON-ALZHEIMER PATHOPHYSIOLOGY WITHIN THE A/T/N FRAMEWORK (2019) (0)
BIOMARKER-BASED POLYGENIC RISK SCORES FOR ALZHEIMER’S DISEASE (2019) (0)
Volumetric, cortical thickness and grey matter density changes on MRI over 12 months: Relationship to conversion status in the ADNI cohort (2009) (0)
Hypertension and race affect cerebral blood flow and cognition in older adults without dementia (2021) (0)
Sparse Bayesian learning for identifying the neuroanatomical basis of cognitive impairment in Alzheimer's disease (2013) (0)
ASSOCIATIONS BETWEEN SOCIAL NETWORK CHARACTERISTICS AND CORTICAL THICKNESS AND HIPPOCAMPAL VOLUME IN COGNITIVELY NORMAL SUBJECTS (2017) (0)
Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study (2012) (0)
Early detection of Alzheimer's disease: Probing mitochondrial function in the periphery (2013) (0)
MODELING MS LESION OBJECTS FOR MEDICAL INFORMATION EXCHANGE (2005) (0)
Neural correlates of semantic processing in older adults with cognitive complaints and amnestic MCI (2009) (0)
Gene-based analyses of microglial activation on [11C] PBR28 PET in older adults at risk for Alzheimer's disease (2013) (0)
Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study (2012) (0)
VISUAL LEARNING ON THE COGSTATE BATTERY IS ASSOCIATED WITH AMYLOID, TAU, AND NEURODEGENERATION IN COGNITIVELY NORMAL OLDER ADULTS (2017) (0)
Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis (2020) (0)
Brain Imaging and Behavior: A Message from the Editor (2010) (0)
Genetic and Structural Network Contributions to The Regional Vulnerability of Tauopathy (2022) (0)
CNV Regions Profiling and Risk Of Cognitive Impairment in the ADNI Sample (2010) (0)
P2-072: Hippocampal and distributed gray matter abnormalities in mild cognitive impairment and early Alzheimer's disease in the Alzheimer's disease neuroimaging initiative baseline 1.5T MRI scans: Cross-sectional analysis and relation to verbal learning (2008) (0)
NEURODEGENERATIVE PATTERNS OF COGNITIVE CLUSTERS OF EARLY ONSET AD SUBJECTS: EVIDENCE FOR DISEASE HETEROGENEITY (2017) (0)
OPTIMIZING COGNITIVE CHANGE INDEX CUTOFFS BASED ON COGNITIVE DECLINE AND BIOMARKER POSITIVITY IN COGNITIVELY NORMAL OLDER ADULTS (2017) (0)
Association of Subjective Cognitive Complaints and Objective Cognitive Impairment in Late Life Depression (2018) (0)
Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N = 1345 young and elderly subjects (2012) (0)
A SIMPLE METHOD FOR DEFINING ATROPHY SUBTYPES IN INDIVIDUAL SUBJECTS ACROSS THE ALZHEIMER’S DISEASE SPECTRUM (2018) (0)
Immunity gene IFITM3 variant: Relation to cognition and Alzheimer's disease pathology (2022) (0)
GENOME-WIDE ASSOCIATION OF TOP ALZHEIMER’S DISEASE ENDOPHENOTYPES IN ADNI DATASET (2018) (0)
Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer’s Disease (2016) (0)
GENOME-WIDE PROTEIN INTERACTION-GUIDED EPISTATIC ANALYSIS ON MEMORY PERFORMANCE: AN ADNI STUDY (2014) (0)
A voxel-based morphometry study of volumetric MRI in familial Alzheimer's disease (2012) (0)
GENETIC VARIATION OF ANTI-AGING GENE FGF23 IS ASSOCIATED WITH LARGER CORTICAL THICKNESS IN ALZHEIMER’S DISEASE (2018) (0)
INCREASED AMYLOID DEPOSITION IN OLDER ADULTS AT RISK FOR PROGRESSION TO ALZHEIMER'S DISEASE DUE TO GENETIC BACKGROUND AND/OR THE PRESENCE OF SIGNIFICANT MEMORY CONCERNS (2014) (0)
Reply (2015) (0)
INCREASED DYNAMIC FLEXIBILITY OF FMRI-DERIVED BRAIN FUNCTIONAL CONNECTIVITY IN PRODROMAL ALZHEIMER’S DISEASE (2019) (0)
Deep learning–based genome‐wide association analysis in Alzheimer’s disease (2021) (0)
A Genome‐Wide Search for Pleiotropy in Cognitive Domain Scores (2022) (0)
Cognitive symptoms in early postmenopausal women: Impact on estrogen‐sensitive cholinergic function (2020) (0)
COMPARATIVE ANALYSIS OF PIB IN VIVO WITH 6-CN-PIB AND AB-IMMUNOHISTOCHEMISTRY POSTMORTEM IN FAMILIAL ALZHEIMER'S DISEASE ASSOCIATED WITH THE PSEN1 I229F MUTATION (2014) (0)
Novel circling SWAT for deep learning based diagnostic classification of Alzheimer’s disease: Application to metabolome data (2022) (0)
Visual contrast sensitivity in MCI and older adults with cognitive complaints is associated with altered resting connectivity in the visual network (2012) (0)
Decreased Dynamic Flexibility of Brain Functional Connectivity in Prodromal Alzheimer’s Disease (2018) (0)
Neuropathological correlates and genetic architecture of microglial activation in elderly human brain (2019) (0)
ELEVATED CEREBRAL BLOOD FLOW IN PARTICIPANTS WITH SUBJECTIVE COGNITIVE DECLINE (2016) (0)
Genetic architecture of resilience of executive functioning (2012) (0)
Functional neuroanatomical correlates of episodic memory impairment in early phase psychosis (2015) (0)
DNA damage in peripheral blood cells is associated with Alzheimer's-related plasma proteins in individuals at risk for progression to Alzheimer's disease (2013) (0)
Effect of hypertension and antihypertensive medication on executive function, brain atrophy, and white matter hyperintensities (2015) (0)
Association of peripheral blood DNA methylation level with Alzheimer’s disease progression (2021) (0)
Re: REST rs3796529 variant does not confer susceptibility to Alzheimer's disease (2015) (0)
PLASMA TAU LEVELS IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE (2016) (0)
ASSOCIATION OF SERUM-BASED PLASMALOGENS WITH NEUROIMAGING AND GENETIC VARIATION IN ALZHEIMER’S DISEASE (2019) (0)
Abstract B111: Black-White differences in physical and cognitive aging among older breast cancer survivors in the Thinking and Living with Cancer Study (2023) (0)
EFFECTS OF CORTICAL AMYLOID B DEPOSITION ON THE INCIDENCE AND PREVALENCE OF NEUROPSYCHIATRIC BEHAVIORS IN THE ELDERLY (2016) (0)
Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (0)
Reply (2015) (0)
Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states (2018) (0)
ADORA2A POLYMORPHISM IS ASSOCIATED WITH CEREBRAL BLOOD FLOW IN MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (2017) (0)
Apolipoprotein E ɛ4–related effects on cognition are limited to the Alzheimer’s disease spectrum (2021) (0)
GENETIC INFLUENCE ON LEVELS OF TARGETED METABOLITES ASSOCIATED WITH ALZHEIMER’S DISEASE (2016) (0)
Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study (2012) (0)
Association of eye disease with increased diffusivity in the sagittal stratum (2015) (0)
Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort (2017) (0)
THE GROWTH AND IMPACT OF ADNI GENETICS PUBLICATIONS AS MEASURED BY SCIENCE MAPPING (2016) (0)
Development and psychometric evaluation of the Test of Practical Judgment alternate form (Form B) (2021) (0)
GENETIC ASSOCIATION OF IMMUNE-RELATED PROTEOMIC ANALYTES FROM PERIPHERAL BLOOD IN MCI AND ALZHEIMER’S DISEASE (2019) (0)
Development and validation of composite scores for language and visuospatial functioning in ADNI (2020) (0)
THE GROWTH AND IMPACT OF ADNI GENETICS PUBLICATIONS AS MEASURED BY SCIENCE MAPPING (2016) (0)
Increased Bridging Characteristics in Social Networks are Associated with Increasing Amygdala Volume and Grey Matter Density (2022) (0)
Gene-based GWAS and biological pathway analysis of the resilience of executive functioning (2013) (0)
Comparison of diffusion weighted, imaging‐derived, fractional anisotropy with a novel MRI contrast‐weighted ratio method for measuring myelin in older adults at risk for Alzheimer’s disease (2021) (0)
Sex‐specific genetic predictors of memory performance (2021) (0)
Genome‐wide association and colocalization analyses identify target genes for brain arteriolosclerosis (2021) (0)
Genetic associations with brain amyloidosis (2020) (0)
The Alzheimer’s metabolome: Identification of novel markers and treatment targets (2015) (0)
Classification of MCI and Alzheimer's disease from CSF biomarkers: An ADNI study of Aß, tau and P-tau versus 83 proteomic analytes (2012) (0)
Genetic drivers of longevity provide protection against Alzheimer's disease pathology (2020) (0)
Common folate genevariant , MTHFR C 677 T , is associatedwithbrain structure in two independent cohorts of people with mild cognitive impairment ☆ (2013) (0)
Worldwide ADNI Update – July , 2012 (2013) (0)
Author Correction: FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2022) (0)
Behavioral Imaging: The Neuropsychological Assessment (1993) (0)
Image‐based modeling of biomechanical factors for risk assessment of developing periventricular white matter hyperintensities (2020) (0)
IC-PL1: Integrating neuroimaging, genomics and cognition in Alzheimer's disease research (2008) (0)
COMPARISON BETWEEN THREE VOLUMETRIC MRI Z-SCORE NORMING METHODS ACROSS THE ALZHEIMER DISEASE SPECTRUM (2018) (0)
INFLUENCE OF MEDICAL COMORBIDITIES ON BIOMARKER-INFORMED COGNITIVE RESERVE IN OLDER ADULTS (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Andrew J. Saykin?

Andrew J. Saykin is affiliated with the following schools:

Indiana University Bloomington
Indiana University
Dartmouth College
Purdue University
Rush University

Andrew J. Saykin's Academic­Influence.com Rankings

Why Is Andrew J. Saykin Influential?

Andrew J. Saykin's Published Works

Published Works

What Schools Are Affiliated With Andrew J. Saykin?

Andrew J. Saykin's AcademicInfluence.com Rankings